aripiprazole has been researched along with risperidone in 453 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 93 (20.53) | 29.6817 |
| 2010's | 274 (60.49) | 24.3611 |
| 2020's | 86 (18.98) | 2.80 |
| Authors | Studies |
|---|---|
| Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
| Glennon, RA | 1 |
| Huang, AS; Kim, SF; Snowman, AM; Snyder, SH; Teuscher, C | 1 |
| Coolen, HK; Glennon, JC; Kruse, CG; Lange, JH; Reinders, JH; Tolboom, JT | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Andreasen, JT; Bernetti, M; Borriello, M; Brindisi, M; Butini, S; Cagnotto, A; Campiani, G; Ceres, N; Coccone, SS; De Angelis, M; Fattorusso, C; Fiorini, I; Franceschini, S; Gemma, S; Mennini, T; Mikkelsen, JD; Nacci, V; Novellino, E; Ros, S; Sandager-Nielsen, K; Scheel-Kruger, J; Trotta, F | 1 |
| Jensen, AA; Kehler, J; Krogsgaard-Larsen, N | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Bundgaard, C; Garmer, M; Jensen, CJ | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bienkowski, P; Bucki, A; Jaśkowska, J; Kazek, G; Kowalski, P; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Mitka, K; Pawłowski, M; Siwek, A; Wasik, A; Wesołowska, A | 1 |
| Andreassi, M; Brindisi, M; Brogi, S; Butini, S; Cagnotto, A; Campiani, G; Casagni, A; Franceschini, S; Gemma, S; Gorelli, B; Mikkelsen, JD; Novellino, E; Ros, S; Salmona, M; Sandager-Nielsen, K; Saponara, S; Scheel-Kruger, J; Trotta, F; Weikop, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bi, M; Chen, W; Guo, S; He, Y; Hu, T; Jiang, X; Li, J; Liu, Y; Shen, J; Wang, Y; Wang, Z; Wu, C; Xie, Y; Xu, M; Yang, F; Yin, J; Zhang, J; Zhao, Q | 1 |
| Akber Aisa, H; Chen, W; Guo, S; He, Y; Hu, T; Jiang, X; Li, J; Liu, Y; Shen, J; Wang, Y; Wang, Z; Wu, C; Xiamuxi, H; Xie, Y; Xu, M; Yang, F; Zhang, J; Zhao, Q | 1 |
| He, Y; Jiang, H; Jiang, X; Li, J; Liu, Y; Shen, J; Tian, G; Wang, Y; Wang, Z; Wu, C; Xu, M; Yang, F; Ye, B; Zhang, J; Zhao, Q | 1 |
| He, Y; Liu, Y; Shen, J; Shi, W; Wang, Y; Wang, Z; Wu, C; Wu, S; Yang, F; Zheng, W | 1 |
| Chen, J; Chen, Y; Gao, L; Hao, C; Jin, J; Liu, BF; Liu, X; Ma, R; Wu, Q; Zhang, G; Zheng, L | 1 |
| Albert, MJ; Baldessarini, RJ; Centorrino, F; Kelleher, JP | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Woods, SW | 1 |
| Altar, CA; Burris, KD; Dunn, B; Hirose, T; Imaoka, T; Kikuchi, T; Miwa, T; Molinoff, PB; Nakai, M; Nakai, S; Okazaki, H; Tottori, K; Uwahodo, Y; Yamada, S | 1 |
| Ali, M; Carson, WH; Ingenito, G; Kujawa, MJ; Marder, SR; Potkin, SG; Saha, AR; Stock, E; Stringfellow, J | 1 |
| Hedges, D; Jeppson, K; Whitehead, P | 1 |
| Tamminga, CA | 1 |
| Buckley, PF; Glazer, W; Sebastian, CS | 1 |
| Ismail, MS; Profenno, LA; Tariot, PN | 1 |
| Altar, CA; Burris, KD; Hirose, T; Kikuchi, T; Kitagawa, H; Miwa, T; Nabeshima, T; Uwahodo, Y; Yamada, S | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Shayegan, DK; Stahl, SM | 1 |
| Citrome, L; Volavka, J | 1 |
| Finkel, S | 1 |
| Katz, IR | 1 |
| Lambert, M; Naber, D | 1 |
| Keck, PE | 1 |
| Aubry, JM; Bertschy, G; Bryois, C; Eliez, S; Etter, M; Nanzer, N | 1 |
| Dubois, D | 1 |
| Winter, AS; Witschy, JK | 1 |
| Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K | 1 |
| Kuehn, BM | 1 |
| Ostroff, R; Wahl, R | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Been, A; de Bruijn, C; Vergouwen, AC | 1 |
| Balit, CR; Isbister, GK; Kilham, HA | 1 |
| Basson, BR; Treuer, T | 1 |
| Howland, RH | 2 |
| Fletcher, PJ; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE | 1 |
| Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R | 1 |
| Ballard, C; Waite, J | 1 |
| Kantrowitz, JT; Srihari, VH; Tek, C | 1 |
| Doraiswamy, PM; Levine, JG; Szarfman, A; Tonning, JM | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Ehret, MJ; Levin, GM | 1 |
| Bies, RR; Chew, ML; Gharabawi, G; Greenspan, A; Kapur, S; Kirshner, MA; Lehman, ME; Mulsant, BH; Pollock, BG | 1 |
| Chen, CK; Lin, SK | 1 |
| De Oliveira, IR; Juruena, MF | 1 |
| Chan, HY; Chiang, SC; Hwang, TJ; Hwu, HG; Lin, SK; Lin, WW; Su, TP | 1 |
| Limosin, F | 1 |
| Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA | 1 |
| Wooten, J | 1 |
| Allen, MH; Nordstrom, K | 1 |
| Jain, R; Skale, TG | 1 |
| Cooper, T; Usubiaga, H; Winsberg, B | 1 |
| Rai, A; Spiegel, D; Urbano, M | 1 |
| Avorn, J; Brookhart, MA; Choudhry, NK; Mogun, H; Patrick, A; Schneeweiss, S; Setoguchi, S; Wang, PS | 1 |
| Perlis, RH | 1 |
| Chou, SY; Chung, PC; Su, JA; Tsang, HY | 1 |
| Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ | 1 |
| Chen, YY; Hung, GC | 1 |
| Corey-Lisle, PK; Crosby, RD; Kan, HJ; Kolotkin, RL; McQuade, RD | 1 |
| Hwang, MY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS | 1 |
| Chang, KD | 1 |
| Findling, RL | 1 |
| Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| Bogeski, M; Gogos, A; van den Buuse, M | 1 |
| Ayache, L; Buysschaert, M; Fagnart, O; Feys, JL; Gruson, D; Hermans, MP; Jamart, J; Luts, A; Mertens de Wilmars, S; Misson, A; Oriot, P | 1 |
| Azzoni, A; Raja, M | 1 |
| Cretaz, E; Diniz, BS; Forlenza, OV | 1 |
| Chen, CH; Lu, ML; Shen, WW | 1 |
| Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Baker, RA; Byerly, MJ; Eudicone, JM; Marcus, RN; Tran, QV; Whitehead, R | 1 |
| Hanssens, L; Kerselaers, W; L'Italien, G; Loze, JY; Marcus, RN; Pans, M | 1 |
| Hauser, D; Ladds, B; Mejia, C; Thomas, P | 1 |
| Assunção-Talbott, S; Crandall, DT; Eudicone, JM; Glick, ID; Janicak, PG; Marcus, RN; Marder, SR; McQuade, RD | 1 |
| Caykoylu, A; Ekinci, O; Yilmaz, E | 1 |
| Carlström, EL; Jazin, E; Jiang, L; Saetre, P | 1 |
| Ascher-Svanum, H; Ball, T; Conley, R; Liu, L; Stauffer, V | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Kalapatapu, RK; Schimming, C | 1 |
| Kahn, JP; Kerselaers, W; Lissens, J; McQuade, RD; Modell, S; Ryckmans, V; Sanchez, R; Werner, C | 1 |
| Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R | 1 |
| Heard, K; Hoppe, J; Tan, HH | 1 |
| Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Chen, CK; Wu, JH | 1 |
| Bian, QT; Chen, JX; Haile, C; Kosten, TR; Liu, YH; Su, YA; Wang, N; Wang, SL; Yang, FD; Zhang, XY | 1 |
| Capote, HA; Gengo, FM; Rainka, MM; Ross, CA | 1 |
| El-Sayeh, HG; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Correll, CU; Kane, JM; Malhotra, AK; Manu, P; Napolitano, B; Olshanskiy, V | 1 |
| Assunção-Talbott, S; Carson, WH; Correll, CU; Goff, DC; Kane, JM; Kirkpatrick, B; Marder, SR; Pikalov, A; Sun, W; Vester-Blokland, E | 1 |
| Leckband, SG; Meyer, JM; Strack, DK | 1 |
| Kim, JJ; Kim, SI; Ku, J; Park, IH; Park, JY; Park, KM | 1 |
| Carbray, MJ; McGuinness, T | 1 |
| Conley, Y; Davies, MA; Roth, BL | 1 |
| Rocha, FF | 1 |
| Helm, ME; Henderson, C; Martin, BC; Pathak, P; West, D | 1 |
| Fujita, K; Fukuo, Y; Furukawa, O; Iwata, N; Kawashima, K; Kishi, T; Kitajima, T; Moriwaki, M; Naitoh, H; Okochi, T | 1 |
| Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Elsom, SJ; Gurvich, C; Kulkarni, J; McCauley-Elsom, K | 1 |
| Guirguis-Blake, J | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Chen, CK; Hsiao, CC; Huang, YS; Ree, SC | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| Fujii, A; Furukori, H; Kaneko, S; Sugawara, N; Yasui-Furukori, N | 1 |
| Atallah, AN; Melnik, T; Puga, ME; Soares, BG | 1 |
| Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Ardizzone, I; Carratelli, TI; Ferrara, M; Marconi, A; Nardecchia, F | 1 |
| Enoksen, TB; Hendset, M; Hermann, M; Molden, E; Refsum, H | 1 |
| Chen, J; Gao, K; Kemp, DE | 1 |
| Fernalld, R; Jordan, S; Kambayashi, J; Kikuchi, T; Koprivica, V; Murphy, JJ; Regardie, K; Wolff, C | 1 |
| Bhutani, T; Busse, KL; Koo, JY; Ladizinski, B | 1 |
| McKinney, C; Renk, K | 1 |
| Ekinci, O; Sabuncuoglu, O | 1 |
| Lee, SY; Pae, CU; Park, MH; Patkar, AA | 1 |
| Depping, AM; Gaudchau, A; Kissling, W; Komossa, K; Leucht, S | 1 |
| Lee, J; Ng, KW; Swapna, V | 1 |
| Arends, J; Cohen, D; van Kooten, M | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Chen, CY; Lin, TY; Shuai, HA; Wang, CC | 1 |
| Aman, MG; Farmer, CA | 1 |
| Bobo, WV; Crystal, S; Gerhard, T; Huang, C; Lieberman, JA; Olfson, M | 1 |
| Atli, A; Aydin, A; Besiroglu, L; Ozdemir, O; Ozdemir, P; Selvi, Y | 1 |
| Gründer, G; Klomp, M; Schiffl, K; Schorn, H; Vernaleken, IB; Veselinović, T | 1 |
| Bernagie, C; De Hert, M; Dockx, L; Leucht, S; Peuskens, B; Peuskens, J; Sweers, K; Tack, J; Van de Straete, S; Wampers, M | 1 |
| Aleman, A; Bous, J; Hollander, K; Knegtering, H; Liemburg, E | 1 |
| Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z | 1 |
| Ahn, YM; Jung, DC; Kang, UG; Kim, EY; Kim, SH; Kim, YS; Lee, NY; Sung, KH; Yu, HY | 1 |
| Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA | 1 |
| Ishitobi, M; Kosaka, H; Murata, T; Shukunami, K; Wada, Y | 1 |
| Kaneda, A; Kaneko, S; Sugawara, N; Tomita, T; Yasui-Furukori, N | 1 |
| Fitzgerald, ME; Fodstad, JC; Matson, JL; Sipes, M | 1 |
| Bous, J; de Boer, MK; Hamamura, T; Knegtering, H; Sytema, S; van der Moolen, AE; Wiersma, D; Wilffert, B | 1 |
| Hamer, RH; LaVange, LM; Lieberman, JA; McEvoy, JP; Nussbaum, AM; Perkins, DO; Ring, KD; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Eberhard, J; Fors, BM; Hansen, K; Lindström, E; Sapin, C | 1 |
| de Arce Cordón, R; Eding, E; Marques-Teixeira, J; Milanova, V; Rancans, E; Schreiner, A | 1 |
| Chou, J; Chung, MT; Lin, CH; Ma, H | 1 |
| Faludi, G; Fejes, L; Inczédy-Farkas, G; Kassai-Farkas, A; Lazáry, J; Makkos, Z | 1 |
| Weiden, PJ | 1 |
| Diaz-Atienza, F; Gurpegui, M; Gutiérrez-Rojas, L; Jurado, D; Martínez-Ortega, JM | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Bschor, T; Erbe, S; Gutwinski, S | 1 |
| Grohmann, R; Holl, AK; Letmaier, M; Painold, A; Vergin, H | 1 |
| Berkowitz, RL; Docherty, JP; Ni, Q; Parks, JJ; Patel, U | 1 |
| Chung, YC; Huang, GB; Lee, KH; Park, CH; Park, MS; Park, TW; Tong, Z; Yang, JC | 1 |
| Asano, M; Hiratani, M; Ishitobi, M; Kosaka, H; Mizuno, T; Murata, T; Takahashi, T; Tomoda, A; Wada, Y | 1 |
| Akiyoshi, J; Hanada, H; Higuma, H; Ishitobi, Y; Isogawa, K; Kanehisa, M; Kodama, K; Maruyama, Y; Tanaka, Y; Tsuru, J | 1 |
| Han, C; Jeong, HG; Joe, SH; Ko, YH; Lee, HY; Lee, MS | 1 |
| Knoepflmacher, D; Shapley, L; Turner, EH | 1 |
| Dunn, G; French, P; Hutton, P; Morrison, AP; Taylor, PJ; Yung, AR | 1 |
| Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
| Anandarajan, T; Bastiampillai, T; Dhillon, R; Tibrewal, P | 1 |
| Abdallah, CG; Hong, X; Huang, H; Huang, Q; Jiang, L; Liang, C; Liu, Y; Wan, X; Wang, J; Wu, R; Xu, C; Zhang, J | 1 |
| Moteshafi, H; Stip, E | 1 |
| Azorin, JM; Gasquet, I; Gierski, F; Leguay, D; Lemogne, C; Limosin, F; Raucher-Chéné, D; Rouillon, F; Schuster, JP | 1 |
| Kanno, K; Katsumi, A; Mashiko, H; Miura, I; Niwa, S; Takeuchi, S; Watanabe, K | 1 |
| Nightingale, S | 1 |
| Yui, K | 1 |
| Stern, AP; Trieu, ML | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Aman, MG; Arnold, LE; Butter, E; Handen, B; Humphries, K; Lecavalier, L; Li, X; McDougle, CJ; Scahill, L; Stigler, KA; Swiezy, NB; Wilson, K | 1 |
| Chung, YC; Huang, GB; Kim, MG; Oh, KY; Park, TW; Yang, JC; Zhao, T | 1 |
| Eisenstein, M | 1 |
| Arndt, S; Glorioso, DK; Golshan, S; Henry, R; Jeste, DV; Jin, H; Kraemer, HC; Mudaliar, S; Shih, PA | 1 |
| Bouvard, S; Ciumas, C; d'Amato, T; Daléry, J; Lerond, J; Lothe, A; Poulet, E; Ryvlin, P; Saoud, M | 1 |
| Bader, M; Klingerman, CM; Lynch, CJ; Stipanovic, ME | 1 |
| Okamoto, Y; Sato, G; Yamashita, H; Yamawaki, S; Yoshimura, S | 1 |
| Higuchi, Y; Kawasaki, Y; Miyanishi, T; Seo, T; Sumiyoshi, T; Suzuki, M | 1 |
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
| Honaker, J; Lohr, WD | 1 |
| Byerly, MJ; Glick, ID; Hamer, RM; Khan, AY; Lamberti, JS; McEvoy, JP; Nasrallah, HA; Ray, N; Steinbook, RM; Stroup, TS | 1 |
| Cheung, C; Chua, SE; Collier, DA; Deng, W; Gong, Q; Huang, C; Jiang, L; Li, M; Li, T; Ma, X; McAlonan, GM; Sham, PC; Wang, Q; Wang, Y | 1 |
| El-Sayeh, HG; Hunger, H; Khanna, P; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Furuya, M; Horiguchi, J; Ieda, M; Liaury, K; Miyaoka, T; Takechi, M; Tsuchie, K; Wake, R | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Li, W; Lv, L; Wang, S; Wang, X; Yang, G; Yang, Y; Zhang, H; Zhao, J | 2 |
| Aitchison, KJ; Almandil, NB; Besag, FM; Liu, Y; Murray, ML; Wong, IC | 1 |
| Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Medvedovici, A; Rădulescu, FŞ; Ranetti, AE; Voicu, V | 1 |
| Brovedani, P; Masi, G; Pfanner, C | 1 |
| Adams, DH; Baygani, S; Kinon, BJ; Kollack-Walker, S; Millen, BA; Velona, I; Walling, DP | 1 |
| Bonete Llácer, JM; García Escudero, MA; Martínez Pastor, CJ; Ziadi Trives, M | 1 |
| Berk, M; Ghanizadeh, A; Sahraeizadeh, A | 1 |
| Barry, SJ; Gaughan, TM; Hunter, R | 1 |
| Altamura, AC; Buoli, M; Serati, M | 1 |
| Horiguchi, J; Ieda, M; Miyaoka, T; Nagahama, M; Tsuchie, K; Wake, R; Yamashita, S | 1 |
| Ishigooka, J; Iwata, N; Nakagome, K; Ohmori, T | 1 |
| Datta, SS; Furtado, VA; Kumar, A; Russell, PS; Wright, SD | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Calabrò, MP; D'Amico, G; Gagliano, A; Germanò, E; Guerriero, L; Ingrassia, M; Italiano, D; Lamberti, M; Privitera, C; Siracusano, R; Spina, E | 1 |
| Ameis, SH; Cole, L; Corbett-Dick, P; Correll, CU | 1 |
| Hendset, M; Hermann, M; Knape, M; Molden, E | 1 |
| Au, RW; Chiu, HF; Dickerson, F; Kreyenbuhl, J; Lai, KY; Man, D; Shum, D; Tang, WK; Ungvari, GS; Wang, CY; Xiang, YT; Yu, X; Zhou, FC; Zhou, JJ; Zhou, Y | 1 |
| Dore, J; Hill, SJ; Hooshmand, F; Ketter, TA; Miller, S; Portillo, N; Wang, PW | 1 |
| Ghanizadeh, A; Haghighi, A | 1 |
| Abdoli, N; Aghaei, A; Bajoghli, H; Brand, S; Farnia, V; Juibari, TA; Shakeri, J; Tatari, F; Yazdchi, K | 1 |
| Aleman, A; Cahn, W; Gijsman, HJ; Hovens, JE; Kahn, RS; Maat, A | 1 |
| Correll, CU; Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Anagnostou, E; Baribeau, DA | 1 |
| Anzai, N; Furukawa, S; Hatsuse, N; Ikebuchi, E; Iwata, K; Kishimoto, T; Matsuda, Y; Sato, S; Watanabe, Y | 1 |
| Alva, G; Brams, M; Citrome, L; Glick, ID; Hochfeld, M; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Pestreich, L; Weiden, PJ; Winseck, A | 1 |
| Gallego, JA; Ikuta, T; Kane, J; Malhotra, AK; Peters, BD; Robinson, DG; Szeszko, PR | 1 |
| Awad, G; Hassan, M; Hsu, J; Loebel, A; Pikalov, A; Rajagopalan, K | 1 |
| Early, M; Erickson, CA; Horn, P; McDougle, CJ; Pottenger, A; Schaefer, T; Wink, LK | 1 |
| Adler, BA; Early, M; Erickson, CA; McDougle, CJ; Minshawi, N; Shaffer, R; Wink, LK | 1 |
| Andrews, G; Boulton, M; Michael, S | 1 |
| Bahramzi, M; Campillo, A; Minassian, A; Vilke, GM; Wilson, MP | 1 |
| Brawman-Mintzer, O; Gros, DF; Hershenberg, R | 1 |
| Csomor, PA; Geyer, MA; Huber, T; Preller, KH; Studerus, E; Vollenweider, FX | 1 |
| Hu, JY; Huang, A; Liu, YY; Liu, ZL; Wang, LM; Wen, XJ | 1 |
| Bagney, A; Caballero, M; Jiménez-Arriero, MA; Rodríguez-Jiménez, R; Torio, I | 1 |
| Makkos, Z | 1 |
| Gu, N; Kane, JM; Li, H; Luo, J; Wang, C; Wang, X; Xie, S; Xu, X; Yu, W | 1 |
| Budman, CL | 1 |
| Morrissette, DA; Stahl, SM | 1 |
| Boettger, S; Breitbart, W; Jenewein, J | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Chiou, CC; Lane, HY; Lin, CY; Tsai, GE; Wang, HS; Wu, VY; Wu, YH | 1 |
| Alva, G; Citrome, L; Glick, ID; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Weiden, PJ; Winseck, A | 1 |
| Argyelan, M; Gallego, JA; Ikuta, T; Kane, JM; Karlsgodt, K; Lencz, T; Malhotra, AK; Robinson, DG; Sarpal, DK; Szeszko, PR | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Aiello, R; Citraro, R; De Sarro, G; Leo, A; Pugliese, M; Russo, E | 1 |
| Ghezai, H; Goldacre, B; Hodsoll, J; Miles, S; Smallcombe, N; Veale, D | 1 |
| Chiu, HF; Dong, H; Han, X; Lu, Z; Ungvari, GS; Wang, CY; Wu, YF; Xiang, YT; Yang, FD; Yu, X; Yuan, YB; Zhao, JP | 1 |
| Crespo-Facorro, B; Prieto, C; Sainz, J | 1 |
| Damkier, P; Ennis, ZN | 1 |
| Berardi, MA; Caraceni, A; Caruso, R; Grassi, L; Mitchell, AJ; Nanni, MG; Riba, M | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Álamo, C; Bernardo, M; Bobes, J; Hidalgo, D; Murru, A; Saiz-Ruiz, J; Vieta, E | 1 |
| van der Weide, J; van der Weide, K | 1 |
| Brooks, KR; Kram, BL; Kram, SJ | 1 |
| Bent, S; Hendren, RL | 1 |
| Bian, QT; Chen, JX; Correll, C; Liu, YH; Soares, JC; Su, YA; Wang, SL; Wei, LH; Yang, FD; Zhang, RZ; Zhang, XY | 1 |
| Hu, LY; Hung, MB; Hung, YY; Lee, YT; Lu, T | 1 |
| Amada, N; Deiana, S; Kikuchi, T; Riedel, G; Stott, C; Watanabe, A; Yamasaki, Y | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Argyelan, M; Gallego, JA; John, M; Kane, JM; Karlsgodt, KH; Lencz, T; Malhotra, AK; Robinson, DG; Sarpal, DK; Szeszko, PR; Weissman, N | 1 |
| Addington, J; Gallego, JA; John, M; Kane, JM; Lencz, T; Malhotra, AK; Robinson, DG; Tohen, M; Yu, J; Zhang, JP | 1 |
| Addington, J; Bennett, N; Braga, RJ; Correll, CU; Gallego, JA; Greenberg, J; Hassoun, Y; John, M; Kane, JM; Kellner, CH; Lencz, T; Lopez, L; Malhotra, AK; Naraine, M; Petrides, G; Robinson, DG; Sevy, SM; Tohen, M; Zhang, JP | 1 |
| Arango, C | 1 |
| Addington, J; Burdick, KE; DeRosse, P; Gallego, JA; Goldberg, TE; Hassoun, Y; John, M; Kane, JM; Kellner, CH; Lencz, T; Malhotra, AK; Petrides, G; Robinson, DG; Tohen, M; Trampush, JW; Zhang, JP | 1 |
| Bereza, BG; Einarson, TR; Goswami, P; Pudas, H; van Impe, K | 1 |
| Dieleman, GC; Dierckx, B; Koch, BC; Touw, DJ; van der Nagel, BC; van Gelder, T; Wijma, RA | 1 |
| Ai, X; Ding, M; Ding, S; Gu, X; Huang, G; Li, X; Lv, L; Pang, L; Song, X; Zhao, J | 1 |
| De Santis, M; Deng, C; Huang, XF; Lian, J | 2 |
| Auricchio, F; Baldelli, S; Bernardini, R; Bertella, S; Bravaccio, C; Capuano, A; Carnovale, C; Cattaneo, D; Clementi, E; Ferrajolo, C; Fucile, S; Guastella, G; Mani, E; Molteni, M; Pascotto, A; Pisano, S; Pozzi, M; Radice, S; Rafaniello, C; Riccio, MP; Rizzo, R; Rossi, F; Scuderi, MG; Sperandeo, S; Sportiello, L; Villa, L | 1 |
| Lahti, AC | 1 |
| Beillat, M; Robinson, P; Sapin, C; Tempest, M; Treur, M | 1 |
| Chawarski, MC; Chen, H; Hao, W; Schottenfeld, RS; Wang, G; Xu, Z; Zhang, S; Zhang, Y | 1 |
| Khouzam, HR | 1 |
| Accordino, RE; Henry, CA; Kidd, C; McDougle, CJ; Politte, LC | 1 |
| Deakin, JF; Dursun, S; Elliott, R; McKie, S; Murphy, A | 1 |
| Bernal, P; Coury, D; Fung, LK; Hardan, AY; Jo, B; Krasner, A; Mahajan, R; Nozzolillo, A; Veenstra-Vanderweele, J; Whitaker, A | 1 |
| Guo, Q; Li, C; Ouyang, Q; Qiao, Y; Shen, W; Sheng, J; Wen, H; Yang, F; Zhu, S | 1 |
| Baymeeva, NV; Burminskiy, DS; Miroshnichenko, II; Morozova, MA; Platova, AI; Potanin, SS | 1 |
| Bieńkowski, P; Jastrzębska-Więsek, M; Kołaczkowski, M; Mierzejewski, P; Partyka, A; Wasik, A; Wesołowska, A | 1 |
| Amato, L; Indave, BI; Minozzi, S; Pani, PP | 1 |
| Uguz, F | 1 |
| Davis, JM; Furtado, VA; Hosalli, P; Sampson, S | 1 |
| Ake, T; Al-Dhaher, Z; Carbon, M; Correll, CU; David, L; Kane, JM; Kapoor, S; Krakower, S; Saito, E | 1 |
| Alosi, N; Cucinotta, F; Di Rosa, G; Gagliano, A; Germanò, E; Italiano, D; Lamberti, M; Siracusano, R; Spina, E | 1 |
| Ariyawansa, J; De Meulder, M; Remmerie, B; Savitz, A | 1 |
| De Meulder, M; Remmerie, B; Savitz, A; Weiner, S | 1 |
| Deng, C; Lian, J; Pan, B | 2 |
| Cocker, KE; Reese, TR; Thiel, DJ | 1 |
| Bruhn, CH; Hashemi, N; Nielsen, J; Polcwiartek, C; Rosenzweig, M; Vang, T | 1 |
| Alonso-Martín, C; Arias-Loste, MT; Crespo, J; Crespo-Facorro, B; Fábrega, E; Martínez-García, O; Morlán-Coarasa, MJ; Ortiz-García de la Foz, V; Romero-Gómez, M | 1 |
| Alphs, L; Correll, CU; Kim, E; Mao, L; Starr, HL | 1 |
| An, FR; Chiu, HF; Jin, X; Li, L; Lok, GK; Ng, CH; Ungvari, GS; Wang, ZM; Wu, PP; Xiang, YT; Yang, R | 1 |
| DeFilippis, M; Wagner, KD | 1 |
| Antoniazzi, S; Auricchio, F; Bernardini, R; Bertella, S; Bravaccio, C; Capuano, A; Carnovale, C; Cattaneo, D; Clementi, E; Ferrajolo, C; Gentili, M; Guastella, G; Mani, E; Molteni, M; Pascotto, A; Pisano, S; Pozzi, M; Radice, S; Rafaniello, C; Riccio, MP; Rizzo, R; Rossi, F; Scuderi, MG; Sperandeo, S; Sportiello, L; Villa, L | 1 |
| Bergmans, P; Caspi, A; Cherubin, P; Hargarter, L; Keim, S; Lara, E; Pinchuk, I; Schreiner, A; Schuepbach, D; Suleman, S | 1 |
| Bernardini, R; Bertella, S; Bravaccio, C; Capuano, A; Carnovale, C; Cattaneo, D; Clementi, E; Ferrajolo, C; Gentili, M; Mani, E; Molteni, M; Pascotto, A; Pisano, S; Pozzi, M; Radice, S; Rafaniello, C; Riccio, MP; Rizzo, R; Rossi, F; Sperandeo, S; Sportiello, L; Sullo, MG; Villa, L | 1 |
| Bervoets, C; Cleymans, S; Morrens, M | 1 |
| Sanchack, KE; Thomas, CA | 1 |
| Kumar C, N; Kumar P B, S; Kumar P T, S; Pandey, RS; Thirthalli, J | 1 |
| Loebel, A; Meyer, N; Rajagopalan, K; Wade, S | 1 |
| Gallego, JA; Malhotra, AK; Rhindress, K; Robinson, DG; Szeszko, PR; Wellington, R | 1 |
| Barber, S; Cipriani, A; Corsi, M; Olotu, U | 1 |
| Arnold, LE; Han, JC; Hellings, JA | 1 |
| Barde, M; Chaumette, B; Gaillard, R; Gay, O; Masson, M | 1 |
| Aleman, A; Knegtering, H; Liemburg, EJ; van Es, F | 1 |
| Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Binici, NC; Güney, SA | 1 |
| Dieleman, GC; Dierckx, B; Kloosterboer, SM; Koch, BCP; Tron, C; van der Nagel, BCH; van Gelder, T; Wijma, RA | 1 |
| Fujibayashi, M; Hattori, S; Hirayasu, Y; Ishii, C; Ishii, N; Kishida, I; Miyauchi, M; Moritani, T; Shiraishi, Y; Suda, A; Taguri, M; Tsujita, N | 2 |
| Baldelli, S; Bernardi, FF; Bernardini, R; Bravaccio, C; Capuano, A; Cattaneo, D; Cheli, S; Clementi, E; Molteni, M; Pozzi, M; Radice, S; Rafaniello, C; Rossi, F; Sessa, M | 1 |
| Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Kawase, H; Matsuda, T; Nakazawa, T; Takuma, K; Tanabe, W; Taruta, A; Tsukada, S | 1 |
| Mock, CK; Teslyar, P; Thom, RP | 1 |
| Hammer, T; Ho, J; Patten, S; Pringsheim, T; Sarna, JR | 1 |
| Naguy, A | 1 |
| Emond, B; Joshi, K; Kamstra, R; Lafeuille, MH; Lefebvre, P; Pilon, D; Tandon, N | 1 |
| Chikodzore, L; Elsemary, A; Nagalingam, P; Seshadri, M; Thalitaya, MD | 1 |
| Dietrich-Muszalska, A; Kolińska-Łukaszuk, J | 1 |
| Bramness, JG; Handal, M; Hartz, I; Hjellvik, V; Nesvåg, R; Skurtveit, S | 1 |
| Baeza, I; de Castro, C; Espinosa, L; Fortea, A; Ilzarbe, D; Oriolo, G; Solerdelcoll, M; Sugranyes, G | 1 |
| Anagnostou, E | 1 |
| Aoki, S; Harada, T; Kishi, Y; Nomura, A; Sato, K; Takeda, T; Washida, K; Yada, Y; Yoshimura, B; Yoshimura, Y | 1 |
| Hu, JQ; Jiang, XJ; Lin, WC; Shang, DW; Shi, L; Wen, YG; Wu, FX; Xiao, B; Zhang, JP; Zhu, HZ | 1 |
| Al-Hassany, L; Bahmany, S; de Winter, BCM; Dekker, A; Dieleman, GC; Dierckx, B; Kloosterboer, SM; Koch, BCP; van Gelder, T | 1 |
| Deng, C; Lian, J | 1 |
| Devriendt, K; Lambrechts, S; Vogels, A | 1 |
| Hibino, H; Inoue, Y; Suzuki, H; Takaya, A | 3 |
| Augusto, M; Greene, M; Sweeney, SM; Touya, M; Waters, H | 1 |
| Gao, LJ; Guo, HG; Liang, ZT; Yang, Y; Zhong, XX; Zhu, JC | 1 |
| Bateman, BT; Cohen, JM; Cohen, LS; Desai, RJ; Glynn, RJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Matsuda, H; Mori, T; Okamoto, K; Ono, S; Ozeki, Y; Sagae, T; Shimoda, K; Someya, T; Sugai, T; Sugawara, N; Suzuki, Y; Yamazaki, M; Yasui-Furukori, N | 1 |
| Fujita, J; Iida, J; Negoro, H; Okada, T; Okumura, Y; Saito, T; Tsujii, N; Usami, M | 1 |
| Flavin, KS; Newcomer, JW; Nicol, GE; Patterson, BW; Schechtman, KB; Schweiger, JA; Yingling, MD | 1 |
| Dong, F; Ji, SM; Li, AN; Li, L; Lu, W; Wang, CY; Zhou, TY | 1 |
| Crespo-Facorro, B; Juncal-Ruiz, M; Leza, JC; López-Hoyos, M; Martínez-Garcia, O; Ocejo-Viñals, JG; Ortiz-García de la Foz, V; Ramírez-Bonilla, M; Riesco-Dávila, L | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gimenez-Donoso, S; Setien-Suero, E; Tirapu-Ustarroz, J; Treen-Calvo, D | 1 |
| Pringsheim, T; Shafiq, S | 1 |
| Hall, W; Maneta, E; Mazher, OA | 1 |
| Barabássy, Á; Daniel, D; Durgam, S; Earley, W; Guo, H; Nasrallah, H; Németh, G; Patel, M; Szatmári, B; Zhong, Y | 1 |
| Dias Alves, M; Micoulaud-Franchi, JA; Simon, N; Vion-Dury, J | 1 |
| Erickson, CA; Lamy, M | 1 |
| Brakoulias, V; Stockings, E | 1 |
| Chhatlani, A; Farheen, SA; Setty, MJ; Tampi, RR | 1 |
| Sakamoto, S; Sato, K; So, R; Tsukahara, M; Yoshimura, B; Yoshimura, Y | 1 |
| Boustany, RM; Khalifeh, S; Kourtian, S; Yassin, W | 1 |
| Bernardini, R; Biganzoli, E; Bravaccio, C; Capuano, A; Carnovale, C; Clementi, E; Marano, G; Molteni, M; Nobile, M; Pisano, S; Pozzi, M; Radice, S; Rafaniello, C; Rizzo, R; Rossi, F | 1 |
| Adamopoulos, P; Budhrani, GS; Easton, GS; Gray, DW; Jabaley, CS; Lynde, GC; O'Reilly-Shah, VN | 1 |
| Beex-Oosterhuis, MM; Dieleman, HG; Eussen, MLJM; Schoemakers, RJ; van Kesteren, C; van Rosmalen, J | 1 |
| Bennett, TA; Beyene, J; Fallah, MS; Neupane, B; Rusiecki, D; Shaikh, MR | 1 |
| Li, P; Liu, X; Wang, J; Wang, Y; Yang, L; Zheng, L; Zhou, H; Zhou, Z | 1 |
| Andreescu, N; Grădinaru, R; Nussbaum, L; Puiu, M; Suciu, L | 1 |
| Fujio, M; Hamamoto, Y; Kano, Y; Kono, T; Matsuda, N; Nonaka, M | 1 |
| Lin, JR; Nakagawasai, O; Nemoto, W; Odaira, T; Onogi, H; Sakuma, W; Srivastava, LK; Takahashi, K; Tan-No, K | 1 |
| Deckert, J; Menke, A; Scherf-Clavel, M; Unterecker, S; Weidner, A | 1 |
| Chakrabarty, T; Keramatian, K; Yatham, LN | 1 |
| Bousman, CA | 1 |
| Haslemo, T; Ingelman-Sundberg, M; Jukic, MM; Molden, E; Smith, RL | 1 |
| Brouillette, M; El Khoury, AC; Joshi, K; Smith, D; Song, X | 1 |
| Abramson, RK; Bradley, C; Bragg, JE; Carpenter, LA; Charles, JM; DeVane, CL; Donovan, JL; Geesey, ME; Gwynette, F; Hall, AG; Kinsman, A; Kruesi, MJ; Powers, NR; Raven, S; Sherk, ST; Spratt, E; Stuck, CA; Williams, JE | 1 |
| Aguglia, E; Arillotta, D; Brondino, N; Damiani, S; Fusar-Poli, L; Petrosino, B; Petrosino, C; Politi, P; Provenzani, U; Rocchetti, M | 1 |
| Effatpanah, M; Khoramizadeh, M; Mahjoub, A; Mostaghimi, A; Rezaei, M; Shishehgar, S | 1 |
| Downing, L; Kim, DD; Procyshyn, RM`; Tibbo, P | 1 |
| Cope, N; Fowler, JC; Knights, J; Makin, A; Peters-Strickland, T; Phiri, P; Rathod, S | 1 |
| Hatano, M; Inagaki, R; Kamei, H; Taniguchi, M; Yamada, S | 1 |
| Huang, A; Loebel, A; Messali, A; Ng-Mak, D; Wang, L | 1 |
| He, S; Li, HF; Li, Y; Li, YG; Qiao, Y; Shen, YF; Wen, H; Yu, YM; Zhang, L; Zhang, Y | 1 |
| Cothros, N; Martino, D; McMorris, C; Pringsheim, T; Stewart, D; Tehrani, A | 1 |
| Cheng, X; Dong, W; Feng, W; Li, H; Wang, M; Zhang, D | 1 |
| Cai, S; Cheng, Z; Correll, CU; Deng, H; Han, X; Lu, Z; Wang, C; Xiang, Y; Yang, F; Yang, L; Yu, X; Yuan, Y; Zhao, J | 1 |
| Iyer, S; Joober, R; Lepage, M; Malla, A; Mustafa, S; Shah, J | 1 |
| Beaulieu, AM; Osser, DN; Tabasky, E | 1 |
| Bai, Y; Chen, G; Gao, K; Yang, H | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Juncal-Ruiz, M; Pelayo-Terán, JM; Romero-Jiménez, R; Setién Suero, E; Suárez-Pinilla, P; Vázquez-Bourgon, J | 1 |
| Chen, Q; Coid, J; Deng, W; Guo, W; Hu, X; Li, K; Li, L; Li, T; Li, X; Li, Y; Lu, T; Lv, L; Ma, X; Ren, H; Reynolds, GP; Tan, L; Tan, Q; Tian, Y; Wang, C; Wang, H; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Goldberg, JF; Hassoun, Y; Sureddi, S; Tohen, M | 1 |
| Escudero, MAG; Gutiérrez-Rojas, L; Lahera, G | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
| Hadryś, T; Rymaszewska, J | 1 |
| Arnaiz, A; Arrue, A; Basterreche, N; Erkoreka, L; González-Torres, MA; Olivas, O; Zamalloa, MI; Zumárraga, M | 1 |
| Ivanov, I; Nicol, GE | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Geng, F; Hao, R; Liu, H; Ning, X; Shi, Y; Xia, L; Zhang, K | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Mayoral-van Son, J; Ortiz-García de la Foz, V; Pelayo-Terán, JM; Vázquez-Bourgon, J | 1 |
| Albarwary, S; Butler, TA; Mustapha, MT; Ozsahin, DU; Ozsahin, I; Sanlidag, B | 1 |
| Aronen, ET; Mogk, H; Rättö, H; Saastamoinen, LK; Varimo, E | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Ortiz-García de la Foz, V; Setién-Suero, E; Suárez-Pinilla, P | 1 |
| Ingelman-Sundberg, M; Jukić, MM; Molden, E; Smith, RL | 1 |
| Kucic, N; Marcelic, M; Petric, D; Racki, V; Stimac, I | 1 |
| Kyriakopoulos, M; Singappuli, P; Sonuga-Barke, E | 1 |
| Liang, J; Shan, F; Zhang, YY; Zhou, XH | 1 |
| de Vries, F; Houghton, R; Law, K; Liu, Y; van den Bergh, J | 1 |
| Shimoda, K; Shinozaki, M; Sugawara, N; Tasaki, M; Yasui-Furukori, N; Yokoyama, S | 1 |
| Çirakli, S | 1 |
| Cortes, ND; Duan, L; Guber, KM | 1 |
| Kyziridis, TC | 1 |
| Baldessarini, RJ; Gaudiot, CES; Nestsiarovich, A; Tohen, M; Vieta, E; Zhu, Y | 1 |
| Abler, V; Rajagopalan, K; Rashid, N; Yunusa, I | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
| Hibino, H; Suzuki, H | 1 |
| Heng, W; Wu, G; Zang, X; Zhu, L | 1 |
| Chen, KL; Chen, SD; Dong, Q; Dou, KX; Huang, YY; Shen, XN; Tan, L; Teng, T; Wang, J; Wang, RZ; Yu, JT; Zhang, RQ; Zhao, QH; Zhong, XL; Zhou, XY | 1 |
| Chen, MH; Escobar Liquitay, CM; Fieiras, C; Franco, JVA; Madrid, E; Meza, N; Rojas, V | 1 |
| Abler, VC; Demos, GN; Mahadik, BS; Rajagopalan, K; Rashid, N; Yunusa, I | 1 |
| Chen, T; Gan, R; Hu, Y; Li, C; Raballo, A; Tang, X; Tang, Y; Wang, J; Wei, Y; Wu, G; Xu, L; Zeng, J; Zhang, T | 1 |
| Cho, J; Jeon, SM; Kwon, JW; Lee, DY | 1 |
| Arango, C; Cabras, A; Cortese, S; Fusar-Poli, P; Hernández, P; Moreno, C; Parellada, M; Pastor Jordá, C; Salazar de Pablo, G; Santosh, P; Simonoff, E; Vaquerizo-Serrano, J; Veenstra-VanderWeele, J | 1 |
| Di Lorenzo, G; Jannini, EA; Jannini, TB; Rossi, R; Sansone, A; Siracusano, A; Toscano, M | 1 |
| Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A | 1 |
| Crespo-Facorro, B; Garrido-Torres, N; Gómez-Revuelta, M; Juncal-Ruiz, M; Mayoral-van Son, J; Ortiz-García de la Foz, V; Vázquez-Bourgon, J | 1 |
| Byeon, SJ; Chung, SJ; Oh, S | 1 |
| Beck, M; Gitahy Falcao Faria, C; Javelot, H; Meyer, G; Michel, B; Riutort, M | 1 |
| Johannesen, CAB; Johnsen, E; Kroken, RA; Larsen, TK; Løberg, EM; Mørkved, N; Rettenbacher, MA; Thimm, JC; Winje, D | 1 |
| Osman, E; Yıldız, M | 1 |
| Choo, H; Jeon, B; Lee, A | 1 |
| Chiappini, S; Giannantonio, MD; Martinotti, G; Miuli, A; Mosca, A; Pettorruso, M; Santovito, MC; Sensi, SL; Skryabin, V | 1 |
| Arango, C; Leucht, S; Lopez-Morinigo, JD | 1 |
| Fukui, T; Fukunaga, H; Hashimoto, M; Ishikawa, T; Koda, Y; Koyama, A; Maruyama, T; Okamoto, K; Sugawara, H; Takebayashi, M | 1 |
| Carter, B; Cleare, AJ; Emre, C; Gnanapragasam, S; Hampsey, E; Korotkova, L; Martín-Dombrowski, J; Marwood, L; Scott, F; Strawbridge, R; Taylor, RW; Young, AH | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Garrido-Sánchez, L; Gómez-Revuelta, M; Juncal-Ruiz, M; Mayoral-Van Son, J; Ortiz-García de la Foz, V; Pelayo-Terán, JM; Ruiz-Veguilla, M; Vázquez-Bourgon, J | 1 |
| Fujii, Y; Misawa, F; Takeuchi, H | 1 |
| Chen, B; Ma, X; Wang, M; Yan, Y; Yang, X; Yin, L | 1 |
| Deng, C; Han, M; Hodgson, J; Lian, J; Su, Y | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Anam, A; Gekhman, D; Lynch, S; Mosharraf, N; Soukas, C | 1 |
| Cao, L; Liu, J; Wu, J | 1 |
| Ahmed, NJ; Alahmari, A; Almalki, ZS; Alshehri, AM | 1 |
| Hu, J; Huang, S; Shang, D; Wen, Y; Xiao, T; Zhu, X | 1 |
| Alamiri, B; Hasan, AE; Jamali, MA; Naguy, A; Pridmore, S | 1 |
| Chen, Q; Deng, W; Du, X; Hao, Q; Hu, X; Li, C; Li, K; Li, L; Li, T; Li, X; Lu, T; Lv, L; Ma, X; Ren, H; Tan, L; Tan, Q; Tang, Y; Wang, C; Wang, L; Wang, Q; Wang, Y; Wu, Y; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Behling, E; Bloch, MH; Farhat, LC; Landeros-Weisenberger, A; Levine, JLS; Macul Ferreira de Barros, P; Wang, Z | 1 |
| de Winter, BCM; Dierckx, B; Hermans, RA; Hillegers, MHJ; Kloosterboer, SM; Koch, BCP; Liang, K; Ringeling, LT | 1 |
| Kverno, K; Ramos-Marcuse, F | 1 |
| Anand, G; Lee, J; Shepperd, R; Smith, M | 1 |
| Akazawa, M; Inada, K; Okada, Y | 1 |
| Boavista, R; Chacon, P; Costa, DLDC; da Silva, RMF; de Barros, PMF; de Mathis, MA; de Oliveira, MVS; Diniz, JB; Echevarria, MAN; Ferrão, YA; Fontenelle, LF; Lopes, AC; Miguel, EC; Rosário, MCD; Shavitt, RG; Torres, AR; Vattimo, EFQ | 1 |
| Carvalho, AF; Hsu, CW; Hsu, TW; Liang, CS; Thompson, T; Tsai, TC; Tseng, PT; Yu, CL | 1 |
| Gupta, B; Lee, J; Pilunthanakul, T; Ting, MQJ | 1 |
| Blanchet, C; Carretier, E; Guessoum, SB; Ludot, M; Moro, MR; Thorey, S | 1 |
| Carlson, HE; Correll, CU; Kazimi, MM; Koch, MT | 1 |
| Bayraktutan, Z; Bulent Yazici, A; Cadirci, E; Cinar, I; Dincer, B; Selli, J; Toktay, E; Yazici, E | 1 |
| Chen, Z; Duan, M; Fang, M; Gao, J; Li, Q; Li, S; Liao, X; Liu, J; Si, T; Su, Y; Wang, C; Wu, B; Xu, J; Yan, S; Yang, Y; Yao, P; Yu, H; Zhang, C | 1 |
| Cheng, Z; Gao, T; Huang, B; Huang, Z; Pu, C; Shi, C; Yu, X; Zhang, D; Zheng, Y; Zhou, E; Zhou, T | 1 |
| Geracioti, TD; Strawn, JR | 1 |
| Feng, X; Kang, Z; Liao, Y; Lu, T; Lu, Z; Sun, Y; Wang, L; Yan, H; Yue, W; Zhang, D; Zhang, Y | 1 |
| Breen, G; Everall, I; Guo, LK; Huang, HL; Huang, Z; Kang, ZW; Li, J; Li, M; Li, WQ; Li, Y; Liao, YD; Liu, B; Lu, TL; Lu, Z; Lv, LX; Su, Y; Tan, YL; Wang, HX; Wang, LF; Xiao, X; Yan, H; Yang, YF; Yao, Y; Yu, H; Yue, WH; Zhang, D; Zhang, YY | 1 |
| Cai, J; Chen, Y; Fang, M; Hu, J; Huang, M; Liu, F; Liu, T; Liu, Z; Long, Y; Meng, H; Song, X; Tang, Y; Wan, C; Wang, X; Wang, Z; Wu, Q; Wu, R; Wu, X; Xiao, J; Xu, X; Xu, Y; Yang, Y; Zhang, R; Zhao, J; Zheng, Y | 1 |
| Apa, H; Kutlu, A; Songür, ÇY | 1 |
| Foreman, K; Loh, R; Thurstone, C; Thurstone, CA; Wolf, C | 1 |
123 review(s) available for aripiprazole and risperidone
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dosage Forms; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2002 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Therapeutic Equivalency; Thiazoles | 2003 |
Antipsychotic medication and seizures: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2003 |
Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Piperazines; Polypharmacy; Quetiapine Fumarate; Quinolones; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Efficacy of atypical antipsychotics in elderly patients with dementia.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
Pharmacology of antipsychotics in the elderly: a focus on atypicals.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Serotonin Antagonists; Thiazoles; Treatment Outcome; United States | 2004 |
Optimizing atypical antipsychotic treatment strategies in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Olanzapine; Parkinson Disease; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
Topics: Antipsychotic Agents; Aripiprazole; Clinical Trials, Phase III as Topic; Haloperidol; Humans; Meta-Analysis as Topic; Piperazines; Quinolones; Risperidone; Schizophrenia; Time Factors | 2004 |
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
[Psychiatry].
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Humans; Lamotrigine; Mental Disorders; Methylphenidate; Piperazines; Quinolones; Risperidone; Triazines | 2005 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Antipsychotic poisoning in young children: a systematic review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Chlorpromazine; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Infant; Infant, Newborn; Olanzapine; Pimozide; Piperazines; Poisoning; Quetiapine Fumarate; Quinolones; Risperidone | 2005 |
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2005 |
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Topics: Aggression; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2006 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Long-term use of atypical antipsychotics in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States | 2006 |
Treatment of psychosis: 30 years of progress.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2006 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
Metabolic effects of the atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Managing the acutely agitated and psychotic patient.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome | 2008 |
The use of atypical antipsychotics in pediatric bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain | 2008 |
Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Dibenzothiazepines; Disorders of Excessive Somnolence; Headache; Humans; Methylphenidate; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2008 |
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
[The use of antipsychotics in patients with dementia].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, Vascular; Dibenzothiazepines; Double-Blind Method; Evidence-Based Medicine; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2008 |
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Evidence-Based Medicine; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2009 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cardiovascular System; Dibenzothiazepines; Drug Overdose; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2009 |
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2009 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Antipsychotics in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes, Gestational; Dibenzothiazepines; Female; Humans; Infant, Newborn; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
Topics: Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Isoxazoles; Meta-Analysis as Topic; Paliperidone Palmitate; Piperazines; Placebos; Pyrimidines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Review Literature as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Male; Multicenter Studies as Topic; Olanzapine; Patient Selection; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Topics: Adult; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Sulpiride | 2011 |
Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Child; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Treatment Outcome | 2011 |
Second-generation antipsychotics for major depressive disorder and dysthymia.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dysthymic Disorder; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Aripiprazole for the treatment of irritability associated with autism.
Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Humans; Irritable Mood; Piperazines; Quinolones; Risperidone | 2011 |
A systematic review of medical treatments for children with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2011 |
Issues in the management of challenging behaviours of adults with autism spectrum disorder.
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Behavior Therapy; Child; Child Development Disorders, Pervasive; Combined Modality Therapy; Humans; Piperazines; Quinolones; Risperidone | 2011 |
[Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium Carbonate; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2012 |
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
Topics: Adult; Affective Disorders, Psychotic; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Hypercholesterolemia; Incidence; Pharmacovigilance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2012 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
Atypical antipsychotics for the treatment of disruptive behavior.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Olanzapine; Pediatrics; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2013 |
Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Weight Gain | 2013 |
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Blood-Brain Barrier; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Prolactin; Pyrimidines; Quinolones; Receptors, Dopamine D2; Risperidone; Stress, Psychological; Sulpiride; Xenobiotics | 2013 |
Schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Clozapine; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2012 |
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2014 |
Atypical antipsychotics for psychosis in adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Molindone; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2013 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome | 2013 |
An update on medication management of behavioral disorders in autism.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Piperazines; Propylamines; Quinolones; Risperidone | 2014 |
Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Generalization, Psychological; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2014 |
Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chemotherapy, Adjuvant; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Synergism; Humans; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Remission Induction; Risperidone; Treatment Outcome; Young Adult | 2014 |
The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.
Topics: Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Humans; Isoxazoles; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Tourette Syndrome; Treatment Outcome | 2014 |
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2014 |
Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Schizophrenia | 2015 |
Management of delirium in palliative care: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cholinesterase Inhibitors; Delirium; Disease Management; Haloperidol; Health Personnel; Humans; Olanzapine; Palliative Care; Quetiapine Fumarate; Risperidone | 2015 |
Antipsychotic switching in schizoaffective disorder: A systematic review.
Topics: Antipsychotic Agents; Aripiprazole; Drug Substitution; Humans; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Thiazoles | 2016 |
Complementary and alternative treatments for autism part 1: evidence-supported treatments.
Topics: Acetylcysteine; Animals; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Complementary Therapies; Disease Models, Animal; Evidence-Based Medicine; Free Radical Scavengers; Gastrointestinal Tract; Humans; Inflammation; Mice; Oxidative Stress; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration; Vitamin B 12 | 2015 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Psychopharmacological interventions in autism spectrum disorder.
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Irritable Mood; Psychotropic Drugs; Risperidone; Stereotyped Behavior | 2016 |
Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Humans; Irritable Mood; Problem Behavior; Risperidone; Self-Injurious Behavior | 2016 |
Antipsychotic medications for cocaine dependence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cocaine-Related Disorders; Haloperidol; Humans; Lamotrigine; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reserpine; Risperidone; Triazines | 2016 |
Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Breast Feeding; Female; Humans; Infant Health; Infant, Newborn; Lactation; Olanzapine; Prospective Studies; Risperidone | 2016 |
Risperidone (depot) for schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delayed-Action Preparations; Humans; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2016 |
Behavioral Disorders in Dementia: Appropriate Nondrug Interventions and Antipsychotic Use.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Behavior Therapy; Benzodiazepines; Cognitive Behavioral Therapy; Dementia; Emotions; Humans; Hypotension, Orthostatic; Metabolic Syndrome; Neuroleptic Malignant Syndrome; Olanzapine; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2016 |
Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Denmark; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Olanzapine; Risk Factors; Risperidone; Young Adult | 2016 |
Autism Spectrum Disorder: Primary Care Principles.
Topics: Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Autism Spectrum Disorder; Autistic Disorder; Behavior Therapy; Child Development Disorders, Pervasive; Child, Preschool; Early Diagnosis; Early Medical Intervention; Humans; Infant; Primary Health Care; Referral and Consultation; Risperidone | 2016 |
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2017 |
Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
Topics: Adolescent; Adult; Amitriptyline; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Brain-Derived Neurotrophic Factor; Child; Dopamine Antagonists; Humans; Irritable Mood; Loxapine; Risperidone | 2017 |
Delirium in hospitalized patients: Risks and benefits of antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Haloperidol; Hospitalization; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2017 |
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders | 2018 |
Using antipsychotics for behavioral problems in children.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Autism Spectrum Disorder; Child; Humans; Irritable Mood; Randomized Controlled Trials as Topic; Risperidone | 2018 |
Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Topics: Adolescent; Aripiprazole; Autism Spectrum Disorder; Child; Comorbidity; Guidelines as Topic; Humans; Irritable Mood; Mental Disorders; Psychotropic Drugs; Randomized Controlled Trials as Topic; Risperidone | 2018 |
A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Obsessive-Compulsive Disorder; Paliperidone Palmitate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2019 |
Use of cariprazine in psychiatric disorders: A systematic review.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder; Humans; Piperazines; Risperidone; Schizophrenia | 2018 |
AUTISM IN REVIEW.
Topics: Aripiprazole; Autism Spectrum Disorder; Central Nervous System Agents; Diagnostic and Statistical Manual of Mental Disorders; Diffusion Tensor Imaging; Fluoxetine; Humans; Risk Factors; Risperidone; White Matter | 2016 |
Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Checklist; Child; Humans; Irritable Mood; Network Meta-Analysis; Randomized Controlled Trials as Topic; Risperidone | 2019 |
Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Humans; Medication Adherence; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2019 |
Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.
Topics: Amphetamine-Related Disorders; Aripiprazole; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Iran; Methylphenidate; Risperidone | 2019 |
The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder.
Topics: Adult; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Clomipramine; Humans; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors | 2019 |
Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?
Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Bipolar Disorder; Female; Humans; North America; Olanzapine; Quetiapine Fumarate; Risperidone; United States; Weight Gain | 2020 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Second Generation Antipsychotics Monotherapy as Maintenance Treatment for Bipolar Disorder: a Systematic Review of Long-Term Studies.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2020 |
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Citalopram; Dementia; Electroconvulsive Therapy; Haloperidol; Humans; Olanzapine; Psychopharmacology; Risperidone | 2021 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
Amisulpride - is it as all other medicines or is it different? An update.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Humans; Neurosecretory Systems; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology | 2020 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Antipsychotic long-term treatment in children and young people: a systematic review and meta-analysis of efficacy and tolerability across mental health and neurodevelopmental conditions.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Humans; Mental Health; Olanzapine; Prolactin; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2022 |
[Clinical pharmacokinetics and pharmaceutical forms of long-acting injectable antipsychotics].
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Humans; Olanzapine; Paliperidone Palmitate; Risperidone | 2022 |
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2022 |
Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review.
Topics: Antipsychotic Agents; Aripiprazole; Dementia; Humans; Olanzapine; Psychotic Disorders; Risperidone | 2021 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis.
Topics: Aripiprazole; Dementia; Donepezil; Humans; Memantine; Network Meta-Analysis; Risperidone; United States | 2022 |
Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews.
Topics: Aripiprazole; Autism Spectrum Disorder; Child; Humans; Risperidone; Systematic Reviews as Topic | 2023 |
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dementia; Humans; Network Meta-Analysis; Off-Label Use; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2022 |
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Risperidone | 2023 |
Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Male; Psychotic Disorders; Risperidone; Sexual Dysfunction, Physiological | 2022 |
Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment.
Topics: Aripiprazole; Autism Spectrum Disorder; Child; Humans; Receptors, Serotonin; Risperidone; Serotonin | 2022 |
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Female; Humans; Male; Mice; Olanzapine; Quetiapine Fumarate; Rats; Risperidone | 2022 |
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic | 2022 |
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression.
Topics: Adult; Aripiprazole; Depression; Depressive Disorder, Major; Humans; Ketamine; Risperidone | 2023 |
Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Network Meta-Analysis; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China.
Topics: Antipsychotic Agents; Aripiprazole; Cost-Benefit Analysis; Humans; Lurasidone Hydrochloride; Olanzapine; Risperidone; Schizophrenia | 2022 |
Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Antipsychotic Agents; Aripiprazole; Child; Clonidine; Female; Humans; Male; Network Meta-Analysis; Randomized Controlled Trials as Topic; Risperidone; Tics; Tourette Syndrome; Young Adult | 2023 |
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brazil; Clomipramine; Humans; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2023 |
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2023 |
Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review.
Topics: Adolescent; Adult; Anorexia Nervosa; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2023 |
79 trial(s) available for aripiprazole and risperidone
| Article | Year |
|---|---|
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Double-Blind Method; Female; Hospitalization; Humans; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; China; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Risperidone; Treatment Outcome | 2007 |
Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children.
Topics: Administration, Oral; Adolescent; Age Factors; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Blood Glucose; Body Mass Index; Child; Chlorpromazine; Fasting; Female; Ghrelin; Glucose; Glucose Tolerance Test; Humans; Insulin; Leptin; Male; Piperazines; Quinolones; Risperidone; Sex Factors; Time Factors; Weight Gain | 2007 |
Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Europe; Female; Humans; Male; Middle Aged; Obesity; Olanzapine; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Self Concept; Social Adjustment | 2008 |
Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperazines; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2008 |
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Severity of Illness Index; Sulpiride; Young Adult | 2008 |
Results of phase 3 of the CATIE schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2009 |
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia; Sex Factors; Substance Withdrawal Syndrome; Young Adult | 2009 |
The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Patient Satisfaction; Piperazines; Prolactin; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Treatment Outcome | 2008 |
Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cognition; Female; Health Status; Humans; Male; Middle Aged; Outpatients; Patient Satisfaction; Piperazines; Prolactin; Quality of Life; Quinolones; Risperidone; Schizophrenia; Sexuality; Treatment Outcome | 2009 |
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Headache; Humans; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2009 |
Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Diagnosis, Computer-Assisted; Female; Humans; Middle Aged; Pilot Projects; Piperazines; Quinolones; Risperidone; Schizophrenia, Paranoid; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; User-Computer Interface; Young Adult | 2009 |
Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Humans; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2011 |
The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Young Adult | 2011 |
Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Prolactin; Quinolones; Receptors, Dopamine D2; Risperidone; Single-Blind Method; Young Adult | 2011 |
An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Mood Disorders; Personal Satisfaction; Pilot Projects; Piperazines; Pleasure; Quinolones; Risperidone; Schizophrenia | 2011 |
Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Olanzapine; Piperazines; Quinolones; Receptors, Dopamine D2; Risperidone; Schizophrenia | 2012 |
A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study).
Topics: Adult; Aripiprazole; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Quinolones; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Young Adult | 2011 |
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dibenzothiazepines; Diet, Reducing; Drug Substitution; Exercise; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides | 2011 |
Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Drug Delivery Systems; Female; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Secondary Prevention; Time Factors | 2012 |
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Neurotoxicity Syndromes; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Severity of Illness Index; Sulpiride; Time Factors; Young Adult | 2012 |
Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2012 |
Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Child, Preschool; Combined Modality Therapy; Comorbidity; Female; Follow-Up Studies; Humans; Male; Parents; Patient Education as Topic; Piperazines; Quinolones; Risperidone; Treatment Outcome | 2012 |
Cognitive effects of a single dose of atypical antipsychotics in healthy volunteers compared with placebo or haloperidol.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognition; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Piperazines; Psychomotor Performance; Quinolones; Risperidone; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Therapeutic Equipoise; Triglycerides; United States | 2013 |
The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Risperidone; Schizophrenia | 2012 |
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Coronary Artery Disease; Dibenzothiazepines; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2013 |
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Amino Acids; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Standard of Care; Treatment Outcome; Young Adult | 2013 |
Effect of the addition of aripiprazole on hyperprolactinemia associated with risperidone long-acting injection.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Biomarkers; Chemistry, Pharmaceutical; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Injections; Male; Middle Aged; Pilot Projects; Piperazines; Prolactin; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors; Treatment Outcome | 2013 |
A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Treatment Outcome | 2014 |
Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Protocols; Female; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Remission Induction; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Treatment Outcome | 2013 |
Predictive value of prospective memory for remission in first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; China; Female; Humans; Male; Memory, Episodic; Olanzapine; Piperazines; Prognosis; Quinolones; Remission Induction; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Quality of Life; Quinolones; Risperidone; Tic Disorders; Treatment Outcome | 2014 |
Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.
Topics: Adolescent; Adult; Amphetamine; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Quinolones; Risperidone; Symptom Assessment; Treatment Outcome; Young Adult | 2014 |
Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Dopamine Antagonists; Drug Monitoring; Emotional Intelligence; Female; Humans; Male; Memory, Short-Term; Middle Aged; Netherlands; Patient Dropouts; Reaction Time; Recognition, Psychology; Risperidone; Schizophrenia; Social Behavior Disorders; Young Adult | 2014 |
Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Drug Synergism; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Behavior; Young Adult | 2014 |
A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aortic Bodies; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Administration Schedule; Drug Substitution; Female; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Piperazines; Piperidines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
White matter changes associated with antipsychotic treatment in first-episode psychosis.
Topics: Anisotropy; Antipsychotic Agents; Aripiprazole; Brain; Diffusion Tensor Imaging; Double-Blind Method; Female; Follow-Up Studies; Humans; Lipoproteins, LDL; Longitudinal Studies; Male; Nerve Fibers, Myelinated; Occipital Lobe; Parietal Lobe; Piperazines; Psychotic Disorders; Quinolones; Risperidone; Young Adult | 2014 |
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Outpatients; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Blood Pressure; China; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hyperprolactinemia; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Weight Gain | 2014 |
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dizziness; Female; Humans; Isoxazoles; Male; Olanzapine; Piperazines; Piperidines; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Cerebral Cortex; Connectome; Corpus Striatum; Drug Monitoring; Episode of Care; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Piperazines; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
The Chinese First-Episode Schizophrenia Trial: background and study design.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; China; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Quinolones; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
Schizophrenia gene expression profile reverted to normal levels by antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Longitudinal Studies; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Transcriptome; Treatment Outcome | 2014 |
Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2015 |
Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Connectome; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Prognosis; Reproducibility of Results; Risperidone; Schizophrenia; Treatment Outcome | 2016 |
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Humans; Male; Outcome Assessment, Health Care; Psychotic Disorders; Risperidone; Schizophrenia; Young Adult | 2015 |
Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Female; Humans; Male; Outcome Assessment, Health Care; Psychotic Disorders; Remission Induction; Risperidone; Schizophrenia; Young Adult | 2015 |
Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Mass Index; Cholesterol; Drug Administration Schedule; Etoposide; Female; Humans; Hyperprolactinemia; Lipoproteins, HDL; Male; Mitoxantrone; Prednisone; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides; Vincristine | 2015 |
Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; China; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risperidone; Treatment Outcome; Young Adult | 2016 |
An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Corpus Striatum; Dopamine; Double-Blind Method; Healthy Volunteers; Humans; Male; Memory, Short-Term; Prefrontal Cortex; Receptors, Dopamine D2; Risperidone | 2016 |
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Female; Humans; Male; Pilot Projects; Risperidone | 2016 |
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Veins; Young Adult | 2016 |
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Middle Aged; Non-alcoholic Fatty Liver Disease; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2016 |
Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Delayed-Action Preparations; Female; Haloperidol; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2016 |
Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dentate Gyrus; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Psychotic Disorders; Risperidone; Young Adult | 2017 |
Effects of aripiprazole versus risperidone on brain activation during planning and social-emotional evaluation in schizophrenia: A single-blind randomized exploratory study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Brain Mapping; Emotions; Female; Humans; Interview, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Problem Solving; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Social Perception; Treatment Outcome | 2017 |
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2017 |
Effects of Risperidone and Aripiprazole on Serum Levels of Prolactin, Testosterone and Estradiol in Female Patients with Schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Estradiol; Female; Humans; Middle Aged; Prolactin; Prospective Studies; Retrospective Studies; Risperidone; Schizophrenia; Testosterone | 2018 |
Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Butyrophenones; Dried Blood Spot Testing; Drug Monitoring; Female; Humans; Male; Middle Aged; Risperidone | 2018 |
Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Drug Costs; Female; Humans; Injections, Intramuscular; Male; Markov Chains; Middle Aged; Paliperidone Palmitate; Piperazines; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult | 2018 |
Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial.
Topics: Abdominal Fat; Absorptiometry, Photon; Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Insulin Resistance; Intention to Treat Analysis; Male; Mental Disorders; Olanzapine; Problem Behavior; Risperidone; Treatment Outcome | 2018 |
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study.
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Cytokines; Female; Humans; Longitudinal Studies; Male; Psychotic Disorders; Risperidone; Treatment Outcome | 2018 |
Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Young Adult | 2019 |
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Double-Blind Method; Female; Humans; Male; Risperidone; Treatment Outcome; Weight Gain | 2019 |
Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Biosensing Techniques; Cloud Computing; Humans; Medical Informatics Applications; Medication Adherence; Mobile Applications; Multicenter Studies as Topic; Olanzapine; Pragmatic Clinical Trials as Topic; Psychiatry; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Tablets; United Kingdom | 2019 |
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Risperidone; Schizophrenia; Young Adult | 2019 |
Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Humans; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Time Factors; Weight Gain; Young Adult | 2019 |
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2020 |
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2020 |
Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Prospective Studies; Psychotic Disorders; Risperidone; Treatment Outcome | 2021 |
Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: A 3-year follow-up comparison.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cognition; Cognition Disorders; Cohort Studies; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Mental Status and Dementia Tests; Middle Aged; Psychotic Disorders; Risperidone; Time Factors; Young Adult | 2021 |
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Lipids; Metabolome; Psychoses, Substance-Induced; Psychotic Disorders; Risperidone | 2022 |
Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial.
Topics: Adverse Childhood Experiences; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Prospective Studies; Risperidone; Schizophrenia | 2022 |
Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Prospective Studies; Psychotic Disorders; Risperidone; Treatment Outcome | 2022 |
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an international multicentre randomised controlled trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug Monitoring; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risperidone; Weight Gain | 2022 |
Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
251 other study(ies) available for aripiprazole and risperidone
| Article | Year |
|---|---|
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase.
Topics: Adenylate Kinase; Animals; Antipsychotic Agents; Enzyme Activation; Hypothalamus; Immunohistochemistry; Mice; Phosphorylation; Receptors, Histamine H1; Weight Gain | 2007 |
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzoxazines; Biogenic Monoamines; Humans; Hyperprolactinemia; Indoles; Metabolic Diseases; Phthalimides; Piperazines; Principal Component Analysis; Pyridines; Radioligand Assay; Receptors, Biogenic Amine; Weight Gain | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding Sites; Drug Design; Drug Evaluation, Preclinical; Humans; Ligands; Mice; Models, Molecular; Molecular Structure; Protein Binding; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D3; Structure-Activity Relationship | 2009 |
Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands.
Topics: Cell Line; HeLa Cells; Humans; Indoles; Ligands; Protein Binding; Pyrazines; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; CHO Cells; Cricetulus; Dementia; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Male; Models, Molecular; Motor Activity; Radioligand Assay; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Sulfonamides | 2014 |
Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies.
Topics: Amides; Animals; Antipsychotic Agents; Behavior, Animal; Dizocilpine Maleate; Dopamine Antagonists; Drug Evaluation, Preclinical; Female; Kinetics; Ligands; Male; Mice; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D3; Schizophrenia; Serotonin Receptor Agonists; Structure-Activity Relationship | 2014 |
Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Dose-Response Relationship, Drug; Mice; Microsomes, Liver; Molecular Structure; Motor Activity; Phencyclidine; Structure-Activity Relationship | 2016 |
Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dogs; Half-Life; Humans; Inhibitory Concentration 50; Mice; Microsomes, Liver; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Structure-Activity Relationship | 2017 |
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine D2 Receptor Antagonists; Humans; Male; Mice, Inbred ICR; Microsomes, Liver; Molecular Structure; Picolinic Acids; Risperidone; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2018 |
Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Structure-Activity Relationship; Triazoles | 2020 |
Discovery of a new class of multi-target heterocycle piperidine derivatives as potential antipsychotics with pro-cognitive effect.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cognition; Dopamine; Drug Design; Humans; Hyperprolactinemia; Mice; Models, Animal; Movement; Piperidines; Protein Binding; Receptors, Histamine H3; Risperidone; Serotonin; Structure-Activity Relationship; Weight Gain | 2021 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Corpus Striatum; Dopamine; Haloperidol; Limbic System; Male; Mice; Mice, Inbred ICR; Piperazines; Quinolones; Risperidone; Time Factors | 2003 |
Similarities and differences among antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2003 |
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blepharoptosis; Catalepsy; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Head Movements; Male; Methoxydimethyltryptamines; Mice; Mice, Inbred ICR; Olanzapine; Piperazines; Prosencephalon; Quinolones; Rats; Rats, Wistar; Risperidone; Serotonin; Stereotyped Behavior | 2004 |
Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Cognition; Dibenzothiazepines; Dose-Response Relationship, Drug; Histamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2004 |
Improvement in tardive dyskinesia with aripiprazole use.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid | 2005 |
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium | 2005 |
FDA warns antipsychotic drugs may be risky for elderly.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dementia; Dibenzothiazepines; Drug Approval; Drug Labeling; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2005 |
Reversal of symptomatic hyperprolactinemia by aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Piperazines; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2005 |
['Awakening': a confusing improvement during treatment with atypical antipsychotic agents].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cognition; Female; Humans; Piperazines; Quality of Life; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2005 |
Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania?
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Quinolones; Research Design; Risperidone; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Atypical antipsychotics: special formulations for acute agitation.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Risperidone; Thiazoles | 2005 |
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Avoidance Learning; Catalepsy; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Immunohistochemistry; Male; Motor Activity; Oncogene Proteins v-fos; Piperazines; Prolactin; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Risperidone | 2006 |
Three cases of risperidone-induced enuresis.
Topics: Aripiprazole; Enuresis; Female; Humans; Middle Aged; Piperazines; Quinolones; Risperidone; Schizophrenia | 2006 |
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amenorrhea; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Olanzapine; Piperazines; Pituitary Neoplasms; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; United States; United States Food and Drug Administration | 2006 |
A model of anticholinergic activity of atypical antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Binding Sites; Clozapine; Cognition Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Cholinergic; Risperidone; Schizophrenia; Thiazoles | 2006 |
Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyslipidemias; Female; Humans; Hyperprolactinemia; Obesity; Piperazines; Quinolones; Risperidone; Schizophrenia, Paranoid; Treatment Outcome; Weight Gain | 2006 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles | 2008 |
Practical strategies for assessing and stabilizing bipolar patients in urgent situations.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Emergency Services, Psychiatric; Humans; Impulsive Behavior; Injections, Intramuscular; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Suicide, Attempted; Thiazoles; Time Factors | 2007 |
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Piperazines; Quinolones; Risperidone; Withholding Treatment | 2007 |
Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Clozapine; Databases, Factual; Dementia; Dibenzothiazepines; Drug Utilization Review; Health Services for the Aged; Humans; Olanzapine; Pharmaceutical Services; Piperazines; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Stroke; Thiazoles; Treatment Outcome | 2007 |
Aripiprazole treatment for risperidone-associated tic movement: a case report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Humans; Male; Piperazines; Quinolones; Risperidone; Schizophrenia; Tic Disorders | 2008 |
Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guidelines as Topic; Humans; Male; Piperazines; Quinolones; Risk Assessment; Risperidone; Schizophrenia | 2009 |
Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Comorbidity; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2008 |
Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Inhibition, Psychological; Male; Mice; Mice, Inbred Strains; Olanzapine; Piperazines; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Reflex, Startle; Risperidone; Serotonin Receptor Agonists; Species Specificity | 2008 |
Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.
Topics: Adiponectin; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia | 2008 |
Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Myocardial Infarction; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Risperidone; Schizophrenia; Valproic Acid | 2009 |
Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Risperidone; Schizophrenia | 2009 |
Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells.
Topics: Alternative Splicing; Antipsychotic Agents; Aripiprazole; Astrocytoma; Benzodiazepines; Cell Line, Tumor; Clozapine; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; Risperidone; RNA-Binding Proteins; RNA, Messenger; Time Factors | 2009 |
Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Update on neuropsychiatric symptoms of dementia: antipsychotic use.
Topics: Aged; Aggression; Antipsychotic Agents; Aripiprazole; Dementia; Geriatric Psychiatry; Humans; Piperazines; Psychotic Disorders; Quinolones; Risperidone; Severity of Illness Index | 2009 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Quinolones; Risperidone | 2009 |
Aripiprazole treatment of risperidone-induced hyperprolactinemia.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Hyperprolactinemia; Piperazines; Prospective Studies; Quinolones; Risperidone; Schizophrenia | 2009 |
Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
Topics: Aripiprazole; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Quinolones; Receptors, Dopamine D2; Risperidone | 2009 |
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Child; Child, Preschool; Cohort Studies; Dibenzothiazepines; Female; Humans; Lipid Metabolism; Lipids; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Weight Gain | 2009 |
Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Male; Medical Audit; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk Factors; Risperidone | 2009 |
Pediatric bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child Psychiatry; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Carbonate; Nursing Assessment; Parents; Patient Education as Topic; Piperazines; Psychiatric Nursing; Psychotherapy; Quinolones; Risperidone; Social Support | 2009 |
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Neuroleptic Malignant Syndrome; Nursing Research; Olanzapine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Quinolones; Receptor, Serotonin, 5-HT2A; Risperidone; Thiazoles | 2011 |
[Aripiprazole-induced stuttering treated with risperidone].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Risperidone; Schizophrenia; Stuttering | 2009 |
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Drug Utilization; Evidence-Based Medicine; Female; Humans; Infant; Insurance Claim Review; Male; Medicaid; Mental Disorders; Off-Label Use; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2010 |
Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.
Topics: Acoustic Stimulation; Adult; Aged; Antipsychotic Agents; Aripiprazole; Asian People; Benzodiazepines; Blinking; Female; Humans; Japan; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Reflex, Startle; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Second-generation antipsychotics cause weight gain in youths.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Dibenzothiazepines; Humans; Olanzapine; Overweight; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Weight Gain | 2010 |
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Young Adult | 2010 |
Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia | 2010 |
Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzamides; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Prolactin; Prospective Studies; Quinolones; Risperidone; Young Adult | 2010 |
Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
Topics: Adult; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Middle Aged; Piperazines; Prolactin; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Humans; Male; Piperazines; Quinolones; Risperidone | 2011 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
The effect of coadministration of duloxetine on steady-state serum concentration of risperidone and aripiprazole: a study based on therapeutic drug monitoring data.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2010 |
Aripiprazole protects cortical neurons from glutamate toxicity.
Topics: Animals; Aripiprazole; Benzodiazepines; Cell Nucleus; Cerebral Cortex; Cytoprotection; Dopamine D2 Receptor Antagonists; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Molecular Imaging; Neurons; Neuroprotective Agents; Olanzapine; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Risperidone; Serotonin 5-HT1 Receptor Antagonists; Signal Transduction; Tetrazolium Salts; Thiazoles | 2011 |
Aripiprazole as a viable alternative for treating delusions of parasitosis.
Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Delusions; Female; Humans; Mental Disorders; Movement Disorders; Parasitic Diseases; Pimozide; Piperazines; Quinolones; Risperidone | 2010 |
Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Humans; Male; Methylphenidate; Piperazines; Psychoses, Substance-Induced; Quinolones; Risperidone | 2011 |
A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
Topics: Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Female; Humans; Inpatients; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain | 2011 |
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagonists; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Pituitary Neoplasms; Quinolones; Risperidone; Schizophrenia; Serotonin Antagonists; Trifluoperazine | 2010 |
Preliminary report: a naturalistic study of the effect of aripiprazole addition on risperidone-related hyperprolactinemia in patients treated with risperidone long-acting injection.
Topics: Adult; Aripiprazole; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Injections; Male; Middle Aged; Piperazines; Quinolones; Risperidone; Schizophrenia | 2011 |
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Dibenzothiazepines; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Clozapine; Constipation; Enema; Fecal Impaction; Female; Gastrointestinal Agents; Humans; Lactulose; Male; Middle Aged; Piperazines; Polyethylene Glycols; Prevalence; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index; Young Adult | 2011 |
The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Asian People; Benzodiazepines; Cohort Studies; Databases, Factual; Female; Hospitals, University; Humans; Male; Medical Records; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Quinolones; Republic of Korea; Retrospective Studies; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2011 |
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult | 2011 |
Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
Topics: Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Piperazines; Quinolones; Risperidone; Schizophrenia | 2011 |
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Models, Economic; National Health Programs; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sweden | 2011 |
Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb.
Topics: Amputation Stumps; Antipsychotic Agents; Aripiprazole; Forearm; Granuloma; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Quinolones; Risperidone; Schizophrenia; Skin Diseases; Treatment Outcome | 2012 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hallucinations; Haloperidol; Humans; Hungary; Male; Marijuana Abuse; Olanzapine; Paranoid Disorders; Piperazines; Psychomotor Performance; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology | 2011 |
Switching antipsychotic medications: not enough, too often, or just right?
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia | 2011 |
Adjunctive antipsychotics for major depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Approval; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration | 2011 |
Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Combinations; Drug Interactions; Female; Haloperidol; Humans; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones; Recurrence; Risperidone | 2012 |
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chi-Square Distribution; Clozapine; Dibenzothiazepines; Humans; Missouri; Olanzapine; Piperazines; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.
Topics: Adolescent; Aripiprazole; Child; Child Development Disorders, Pervasive; Drug Substitution; Female; Humans; Male; Piperazines; Quinolones; Retrospective Studies; Risperidone; Treatment Outcome; Young Adult | 2012 |
Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2012 |
Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Prolactin; Prospective Studies; Quinolones; Retreatment; Risperidone; Schizophrenia; Sex Hormone-Binding Globulin; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sulpiride; Testosterone | 2012 |
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Databases, Factual; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Publication Bias; Pyrimidines; Quetiapine Fumarate; Quinolones; Risperidone; United States; United States Food and Drug Administration | 2012 |
Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Interpretation, Statistical; Dibenzothiazepines; Humans; Olanzapine; Patient Dropouts; Piperazines; Quetiapine Fumarate; Quinolones; Review Literature as Topic; Risperidone; Schizophrenia; Sulpiride | 2012 |
Hyperprolactinaemia on depot risperidone treated with aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Drug Monitoring; Drug Substitution; Female; Humans; Hyperprolactinemia; Medication Therapy Management; Pharmacovigilance; Piperazines; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2012 |
Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Auditory Cortex; Benzodiazepines; Dibenzothiazepines; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Reaction Time; Receptor, Adenosine A2A; Risperidone; Schizophrenia; Sensory Gating; Up-Regulation | 2012 |
Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Clozapine; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Quinolones; Risperidone; Schizophrenia; Weight Loss | 2012 |
Autism spectrum disorders.
Topics: Adolescent; Aripiprazole; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Humans; Piperazines; Quinolones; Risperidone | 2012 |
[Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders].
Topics: Administration, Inhalation; Antipsychotic Agents; Arachidonic Acid; Aripiprazole; Child Development Disorders, Pervasive; Child, Preschool; Humans; Interpersonal Relations; Oxytocin; Piperazines; Quinolones; Risperidone | 2012 |
A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Blood Glucose; Diabetes Mellitus, Type 1; Hospitalization; Humans; Hyperglycemia; Language Disorders; Learning Disabilities; Male; Piperazines; Quinolones; Risperidone | 2012 |
Treatments: In the waiting room.
Topics: Adolescent; Adult; Animals; Aripiprazole; Autistic Disorder; Brain; Child; Clinical Trials as Topic; Drug Approval; Drug Repositioning; Humans; Oxytocin; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Trichuris; United States; United States Food and Drug Administration | 2012 |
Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Case-Control Studies; Cerebral Cortex; Drug Partial Agonism; Female; Humans; Magnetic Resonance Imaging; Male; Olanzapine; Piperazines; Positron-Emission Tomography; Pyridines; Quinolones; Radiopharmaceuticals; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2013 |
Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Astemizole; Behavior, Animal; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Epoxy Compounds; Fatty Acids; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Olanzapine; Oxygen Consumption; Piperazines; Quinolones; Receptors, Histamine H1; Respiration; Risperidone; Terfenadine; Time Factors | 2014 |
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Electroencephalography; Evoked Potentials; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Young Adult | 2013 |
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
Topics: Adolescent; Adult; Anisotropy; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Brain Mapping; Case-Control Studies; Dibenzothiazepines; Diffusion Tensor Imaging; Female; Frontal Lobe; Gyrus Cinguli; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Young Adult | 2013 |
The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Haloperidol; Hyperbilirubinemia; Inhibition, Psychological; Locomotion; Male; Neuropsychological Tests; Piperazines; Quinolones; Rats; Rats, Gunn; Reflex, Startle; Risperidone; Schizophrenia; Social Behavior; Treatment Outcome | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia.
Topics: Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Asian People; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; DNA; Estrogen Receptor alpha; Female; Genotype; Haplotypes; Humans; Kaplan-Meier Estimate; Male; Piperazines; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Chi-Square Distribution; Child; Drug Synergism; Female; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tics | 2013 |
Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Substitution; Humans; Male; Perceptual Disorders; Quality of Life; Risperidone; Schizophrenia, Catatonic; Treatment Outcome | 2016 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
ECG parameters in children and adolescents treated with aripiprazole and risperidone.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Electrocardiography; Female; Heart Rate; Humans; Male; Mental Disorders; Piperazines; Prospective Studies; Quinolones; Retrospective Studies; Risperidone | 2014 |
Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Piperazines; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Quinolones; Risk Assessment; Risperidone | 2013 |
Serum concentrations of risperidone and aripiprazole in subgroups encoding CYP2D6 intermediate metabolizer phenotype.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Antipsychotic Agents; Aripiprazole; Child; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Middle Aged; Phenotype; Piperazines; Quinolones; Retrospective Studies; Risperidone; Young Adult | 2014 |
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Topics: Academic Medical Centers; Adult; Ambulatory Care Facilities; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; California; Dibenzothiazepines; Drug Therapy; Female; Humans; Lamotrigine; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Referral and Consultation; Risperidone; Triazines | 2014 |
Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Mass Index; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Weight Gain; Young Adult | 2014 |
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Intellectual Disability; Male; Middle Aged; Pilot Projects; Piperazines; Quinolones; Retrospective Studies; Risk Factors; Risperidone; Self-Injurious Behavior; Treatment Failure; Young Adult | 2015 |
Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Young Adult | 2014 |
Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Topics: Administration, Oral; Adult; Alcoholic Intoxication; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Service, Hospital; Female; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2014 |
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
Topics: Acoustic Stimulation; Amisulpride; Antipsychotic Agents; Aripiprazole; Auditory Perception; Benzhydryl Compounds; Brain; Double-Blind Method; Electroencephalography; Electromyography; Humans; Lorazepam; Male; Modafinil; Piperazines; Prepulse Inhibition; Psychometrics; Psychotropic Drugs; Quinolones; Risperidone; Sensory Gating; Sulpiride; Valproic Acid; Young Adult | 2014 |
[Psychosis due to vitamin B12 deficiency in an elderly patient].
Topics: Aged; Antipsychotic Agents; Aripiprazole; Female; Gastritis, Atrophic; Humans; Paranoid Disorders; Piperazines; Psychological Tests; Quinolones; Remission Induction; Risperidone; Vitamin B 12; Vitamin B 12 Deficiency | 2014 |
[Antipsychotics -- do they exist?].
Topics: Adaptation, Psychological; Affect; Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Corpus Striatum; Depressive Disorder, Major; Dopamine; Dopamine Agents; Humans; Obsessive-Compulsive Disorder; Off-Label Use; Piperazines; Psychotic Disorders; Quinolones; Risperidone; Stress, Psychological; Thinking | 2014 |
Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population.
Topics: Adult; Age of Onset; Aripiprazole; China; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; MicroRNAs; Phenotype; Piperazines; Polymorphism, Genetic; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2014 |
Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Dementia; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone | 2015 |
Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Emergency Service, Hospital; Female; Hospitalization; Humans; Male; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Taiwan; Treatment Outcome | 2014 |
Atypical antipsychotics are not all alike: side effects and risk assessment.
Topics: Antipsychotic Agents; Aripiprazole; Decision Making; Humans; Mental Disorders; Off-Label Use; Patient Education as Topic; Piperazines; Quinolones; Risk Assessment; Risperidone | 2014 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Disease Models, Animal; Epilepsy; Haloperidol; Mental Disorders; Olanzapine; Quetiapine Fumarate; Rats; Risperidone; Seizures | 2015 |
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
Topics: Adolescent; Adult; Alleles; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genotype; Haloperidol; Heterozygote; Humans; Male; Middle Aged; Pimozide; Polymorphism, Single Nucleotide; Retrospective Studies; Risperidone; Schizophrenia; Young Adult | 2015 |
Implications of atypical antipsychotic prescribing in the intensive care unit.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Delirium; Disorders of Excessive Somnolence; Female; Humans; Inappropriate Prescribing; Intensive Care Units; Male; Middle Aged; Olanzapine; Patient Discharge; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survivors; Thiazoles | 2015 |
Using aripiprazole to treat new-onset hyperprolactinemia-related delusion of pregnancy.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Delusions; Female; Humans; Hyperprolactinemia; Risperidone; Schizophrenia | 2015 |
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol.
Topics: Animals; Aripiprazole; Benzodiazepines; Cannabidiol; Dizocilpine Maleate; Dopamine Antagonists; Male; Memory; Models, Animal; Olanzapine; Rats; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Social Behavior | 2015 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Genetic Loci; Humans; Male; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Psychotic Disorders; Randomized Controlled Trials as Topic; Receptors, Dopamine D2; Risk; Risperidone; Schizophrenia; Young Adult | 2015 |
First-Episode Psychosis Research: Time to Move Forward (by Looking Backwards).
Topics: Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Outcome Assessment, Health Care; Psychotic Disorders; Risperidone; Schizophrenia | 2015 |
Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Finland; Humans; Male; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia | 2016 |
Identification and quantification of the antipsychotics risperidone, aripiprazole, pipamperone and their major metabolites in plasma using ultra-high performance liquid chromatography-mass spectrometry.
Topics: Antipsychotic Agents; Aripiprazole; Butyrophenones; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Reference Standards; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry | 2016 |
Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats.
Topics: Age Factors; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Depression; Female; Male; Motor Activity; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone; Sex Factors; Time Factors | 2016 |
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Monitoring; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2016 |
Making Progress Toward Individualized Medicine in the Treatment of Psychosis.
Topics: Aripiprazole; Corpus Striatum; Ether-A-Go-Go Potassium Channels; Female; Humans; Male; Risperidone; Schizophrenia | 2016 |
Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Computer Simulation; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Humans; Injections, Intramuscular; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; State Medicine; United Kingdom | 2015 |
Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Estradiol; Female; Humans; Hyperprolactinemia; Middle Aged; Paliperidone Palmitate; Prolactin; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2016 |
[Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation].
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Depression; Drug Therapy, Combination; Female; Haloperidol; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2015 |
ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Isoxazoles; Male; Maze Learning; Mice; Motor Activity; Olanzapine; Punishment; Rats, Wistar; Reaction Time; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Sulfonamides | 2016 |
Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.
Topics: Adolescent; Aripiprazole; Arousal; Benzodiazepines; Child; Cohort Studies; Female; Humans; Male; Olanzapine; Patient Outcome Assessment; Psychomotor Agitation; Quetiapine Fumarate; Risperidone; Schizophrenia, Childhood; Schizophrenic Psychology; Wakefulness | 2016 |
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Veins; Young Adult | 2016 |
Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Autoradiography; Benzodiazepines; Female; Male; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia | 2016 |
Hyperprolactinemia, prolactin-related side effects and quality of life in Chinese psychiatric patients.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Case-Control Studies; China; Clozapine; Female; Humans; Hyperprolactinemia; Male; Mental Disorders; Quality of Life; Risperidone; Sexual Dysfunction, Physiological; Young Adult | 2016 |
Treatment of Autism Spectrum Disorder in Children and Adolescents.
Topics: Adolescent; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Child; Humans; Irritable Mood; Risperidone; Serotonin Antagonists | 2016 |
Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Child; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Mental Disorders; Outcome Assessment, Health Care; Outpatients; Risperidone; Sex Factors; Tic Disorders | 2016 |
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Substitution; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Patient Satisfaction; Prospective Studies; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome | 2017 |
Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug Substitution; Female; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Risperidone | 2016 |
Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Caudate Nucleus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Hippocampus; Male; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Synaptic Transmission; Time Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2016 |
Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Belgium; Benzodiazepines; Cross-Sectional Studies; Drug Industry; Drug Prescriptions; Drug Utilization Review; Female; Humans; Male; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia | 2017 |
A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2017 |
Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Insurance Claim Review; Lurasidone Hydrochloride; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; United States | 2017 |
[Switching from antipsychotics to aripiprazole and risk of agitation].
Topics: Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Female; Humans; Psychomotor Agitation; Risk; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2018 |
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Epistaxis; Humans; Male; Mood Disorders; Risperidone | 2017 |
Dried Blood Spots Combined With Ultra-High-Performance Liquid Chromatography-Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites.
Topics: Antipsychotic Agents; Aripiprazole; Butyrophenones; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Female; Humans; Male; Risperidone; Tandem Mass Spectrometry | 2017 |
Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
Topics: Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Autonomic Nervous System Diseases; Benzodiazepines; Cross-Sectional Studies; Electrocardiography; Female; Heart Rate; Humans; Japan; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2018 |
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.
Topics: Adolescent; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Neoplasm Proteins; Olanzapine; Pediatrics; Polymorphism, Genetic; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Dendritic Spines; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Haloperidol; Male; Mice; Mice, Inbred ICR; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Risperidone; Social Behavior; Valproic Acid | 2017 |
Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome: A Prospective Longitudinal Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Body Mass Index; Child; Drug Monitoring; Feasibility Studies; Female; Humans; Insulin; Longitudinal Studies; Male; Prolactin; Prospective Studies; Risperidone; Tourette Syndrome; Waist Circumference; Withholding Treatment | 2017 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome | 2017 |
Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost Savings; Delayed-Action Preparations; Female; Health Care Costs; Hospitalization; Humans; Injections; Long-Term Care; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Paliperidone Palmitate; Practice Patterns, Physicians'; Risperidone; Schizophrenia; United States; Young Adult | 2017 |
Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
Topics: Adult; Antipsychotic Agents; Aripiprazole; England; Humans; Mental Health; Practice Patterns, Physicians'; Risperidone; Rural Population; Schizophrenia | 2017 |
Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood; Clozapine; Female; Humans; Lipid Peroxidation; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Thiobarbituric Acid Reactive Substances; Young Adult | 2018 |
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Comorbidity; Depressive Disorder, Major; Female; Humans; Incidence; Infant; Male; Mental Disorders; Norway; Olanzapine; Prevalence; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2018 |
Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Child; Delayed-Action Preparations; Female; Hospitalization; Humans; Inpatients; Male; Off-Label Use; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Risperidone; Treatment Outcome | 2018 |
Two-year effectiveness of risperidone and aripiprazole in the maintenance treatment of patients with recent-onset or chronic schizophrenia and related psychotic disorders: a retrospective multicenter study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Hospitals, Psychiatric; Humans; Middle Aged; Psychotic Disorders; Retrospective Studies; Risperidone; Schizophrenia; Survival Analysis; Young Adult | 2018 |
The effects of antipsychotics on the density of cannabinoid receptors in selected brain regions of male and female adolescent juvenile rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Autoradiography; Benzodiazepines; Brain; Brain Chemistry; Female; Male; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Risperidone; Sex Factors | 2018 |
Low-Dose Aripiprazole and Risperidone for Treating Problem Behavior in Children With Pitt-Hopkins Syndrome.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Facies; Female; Humans; Hyperventilation; Intellectual Disability; Problem Behavior; Risperidone | 2018 |
Changes in length of hospital stay and number of hospitalization before and after the administration of three second-generation antipsychotics long-acting injections in patients with schizophrenia: Mirror-image study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Hospitalization; Humans; Length of Stay; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Treatment Outcome | 2018 |
[Aripiprazole for drug-induced sexual dysfunction in schizophrenic males].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Male; Prolactin; Risperidone; Schizophrenia; Sexual Behavior; Sexual Dysfunction, Physiological; Sulpiride; Testosterone; Treatment Outcome | 2017 |
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes, Gestational; Female; Humans; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles; Young Adult | 2018 |
High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Body Mass Index; Cholesterol, HDL; Correlation of Data; Female; Humans; Japan; Male; Middle Aged; Olanzapine; Overweight; Prevalence; Risperidone; Schizophrenia; Surveys and Questionnaires; Waist Circumference | 2018 |
Glucose and Prolactin Monitoring in Children and Adolescents Initiating Antipsychotic Therapy.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Insurance Claim Review; Japan; Male; Mass Screening; Prolactin; Retrospective Studies; Risperidone | 2018 |
[Using the cumulative odds Logit model to explore the application of the questionnaire derived from PANSS].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Logistic Models; Olanzapine; Risperidone; Schizophrenia; Surveys and Questionnaires | 2016 |
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Autonomic Nervous System; Cross-Sectional Studies; Female; Heart Rate; Humans; Male; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia | 2018 |
[Evaluation of verbal inhibitory control with the Stroop Test in early episodes of psychosis with the experience of traumatic events in infancy].
Topics: Adolescent; Age Factors; Aripiprazole; Child; Child, Preschool; Executive Function; Female; Humans; Infant; Inhibition, Psychological; Male; Prefrontal Cortex; Psychotic Disorders; Risperidone; Stress Disorders, Traumatic; Stroop Test; Surveys and Questionnaires; Verbal Behavior | 2018 |
Treatment of Risperidone-Associated Hyperprolactinemia With Aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Female; Humans; Hyperprolactinemia; Risperidone | 2018 |
Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Glycogen Synthase Kinase 3 beta; Male; Nucleus Accumbens; Olanzapine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Risperidone; Signal Transduction | 2018 |
Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Injections; Japan; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index | 2018 |
Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cerebral Cortex; Clozapine; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Cohort Studies; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Injections; Male; Middle Aged; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2018 |
Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Predictive Value of Tests; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2019 |
Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Mass Index; Body Weight; Child; Female; Humans; Male; Outpatients; Risperidone; Weight Gain | 2019 |
Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational Study.
Topics: Adult; Aged; Anesthesia Recovery Period; Antiemetics; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Postoperative Nausea and Vomiting; Propensity Score; Protective Factors; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Time Factors | 2020 |
No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Body Mass Index; Child; Female; Humans; Male; Netherlands; Psychotic Disorders; Retrospective Studies; Risperidone; Time Factors; Weight Gain | 2019 |
Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling.
Topics: Amisulpride; Antipsychotic Agents; Apoptosis; Aripiprazole; beta Catenin; Cell Line; Humans; Olanzapine; Osteoblasts; Resveratrol; Risperidone; Wnt Signaling Pathway | 2019 |
Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients.
Topics: Adolescent; Alleles; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Cytochrome P-450 CYP2D6; Female; Humans; Hyperprolactinemia; Male; Phenotype; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Young Adult | 2019 |
Expert consensus on pharmacotherapy for tic disorders in Japan.
Topics: Adult; Aged; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Comorbidity; Consensus; Drug Therapy; Expert Testimony; Female; Health Knowledge, Attitudes, Practice; Humans; Japan; Male; Middle Aged; Physicians; Risperidone; Surveys and Questionnaires; Tic Disorders; Tics; Tourette Syndrome | 2019 |
Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Clozapine; Disease Models, Animal; Female; Haloperidol; Hippocampus; Methylazoxymethanol Acetate; Mice; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Risperidone; Schizophrenia | 2019 |
Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; C-Reactive Protein; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; Young Adult | 2020 |
CYP2D6 testing to guide risperidone and aripiprazole therapy.
Topics: Antipsychotic Agents; Aripiprazole; Cohort Studies; Cytochrome P-450 CYP2D6; Genotype; Retrospective Studies; Risperidone | 2019 |
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Middle Aged; Norway; Pharmacogenomic Variants; Psychotic Disorders; Retrospective Studies; Risperidone; Treatment Failure; Young Adult | 2019 |
Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia.
Topics: Administration, Oral; Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Comorbidity; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Insurance Claim Review; Kaplan-Meier Estimate; Longitudinal Studies; Male; Medicaid; Medication Adherence; Middle Aged; Paliperidone Palmitate; Proportional Hazards Models; Racial Groups; Retrospective Studies; Risperidone; Schizophrenia; Sex Factors; United States | 2019 |
Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
Topics: Adolescent; Adult; Aripiprazole; Autism Spectrum Disorder; Benzodiazepines; Child; Comorbidity; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; Irritable Mood; Italy; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Psychotropic Drugs; Risperidone; Young Adult | 2019 |
Management of sexual adverse effects induced by atypical antipsychotic medication
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2019 |
Factors That Affect Continuation of Antipsychotic Long-Acting Injections.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Risperidone; Schizophrenia | 2019 |
Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Female; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia | 2019 |
Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; China; Female; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Young Adult | 2019 |
Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Female; Guanfacine; Humans; Infant; Male; Pharmacoepidemiology; Prescriptions; Risperidone; Tic Disorders; Tourette Syndrome | 2019 |
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Risperidone; Tandem Mass Spectrometry | 2020 |
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States | 2020 |
Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Injections; Injections, Intramuscular; Medication Adherence; Patient Selection; Practice Guidelines as Topic; Risperidone | 2020 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Paliperidone Palmitate; Prolactin; Risperidone | 2021 |
Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Psychiatry; Drug-Related Side Effects and Adverse Reactions; Humans; Obesity; Precision Medicine; Psychopharmacology; Risperidone | 2021 |
Cognitive improvement function of aripiprazole in adolescents with first-episode and repeated-episode schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Cognition; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2021 |
An investigation to choose the proper therapy technique in the management of autism spectrum disorder.
Topics: Aripiprazole; Autism Spectrum Disorder; Fuzzy Logic; Humans; Risperidone | 2021 |
Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study.
Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Duration of Therapy; Female; Finland; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates.
Topics: Adult; Alleles; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Female; Genotype; Haplotypes; Humans; Male; Middle Aged; Phenotype; Retrospective Studies; Risperidone; Venlafaxine Hydrochloride | 2021 |
Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells.
Topics: Antipsychotic Agents; Aripiprazole; Cell Survival; Cells, Cultured; Haloperidol; Humans; Inflammation Mediators; Microglia; Risperidone | 2021 |
Infection is associated with elevated serum concentrations of antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Clozapine; Humans; Quetiapine Fumarate; Respiratory Tract Infections; Risperidone | 2021 |
Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Cohort Studies; Female; Fractures, Bone; Humans; Male; Retrospective Studies; Risperidone; United States | 2021 |
Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.
Topics: Antipsychotic Agents; Aripiprazole; Female; Genetic Diseases, Inborn; Humans; Hyperprolactinemia; Lactation Disorders; Male; Paliperidone Palmitate; Prolactin; Risperidone; Schizophrenia; Testosterone | 2021 |
Childhood dystonic reactions in the middle Black Sea region.
Topics: Age of Onset; Antipsychotic Agents; Aripiprazole; Biperiden; Child; Disease Susceptibility; Dopamine D2 Receptor Antagonists; Dystonia; Female; Humans; Injections, Intramuscular; Male; Medical History Taking; Metoclopramide; Parasympatholytics; Risperidone; Treatment Outcome; Turkey | 2021 |
Risk of Obesity Among Children Prescribed Atypical Antipsychotics for Six Months or More.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Humans; Infant; Male; Obesity; Retrospective Studies; Risperidone | 2022 |
Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Humans; Paliperidone Palmitate; Risperidone; Schizophrenia | 2022 |
A comparative study of olanzapine, aripiprazole and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Retrospective Studies; Risperidone; Time Factors; Treatment Outcome | 2021 |
Antipsychotic Exposure in Clinical High Risk of Psychosis: Empirical Insights From a Large Cohort Study.
Topics: Antipsychotic Agents; Aripiprazole; Cohort Studies; Female; Humans; Male; Psychotic Disorders; Risk Assessment; Risperidone | 2022 |
Comparison of prediction methods for treatment continuation of antipsychotics in children and adolescents with schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Humans; Machine Learning; Risperidone; Schizophrenia | 2022 |
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles | 2022 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Suicidality and psychotic episodes after starting aripiprazole: two case reports.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Male; Paliperidone Palmitate; Risperidone; Suicide | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Prospective clinical intervention study of aripiprazole and risperidone in the management of postoperative delirium in elderly patients after cardiovascular surgery.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Delirium; Humans; Prospective Studies; Risperidone; Treatment Outcome | 2022 |
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Risperidone; Schizophrenia; Tardive Dyskinesia | 2022 |
The long-lasting effects of early antipsychotic exposure during juvenile period on adult behaviours - A study in a poly I:C rat model.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Poly I-C; Pregnancy; Rats; Risperidone | 2022 |
Aripiprazole: examining the clinical implications of D2 affinity.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Paliperidone Palmitate; Risperidone; Schizophrenia | 2023 |
Drug-induced weight gain in the last 10 years: a descriptive study.
Topics: Adalimumab; Adverse Drug Reaction Reporting Systems; Aripiprazole; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Etanercept; Humans; Prednisone; Pregabalin; Retrospective Studies; Risperidone; United States; Weight Gain | 2022 |
Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Electronic Health Records; Humans; Machine Learning; Male; Olanzapine; Pharmacovigilance; Prolactin; Risperidone | 2022 |
Agomelatine Monotherapy for Autism-A Case Report.
Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Humans; Risperidone | 2022 |
Evidence-Based Use of Atypical Antipsychotics in the Care of Children and Adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Humans; Risperidone | 2023 |
Recognising side effects of antipsychotics in children with intellectual disabilities.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Intellectual Disability; Risperidone | 2023 |
Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia | 2023 |
The impact of adjunctive aripiprazole on QT interval: A 12-week open label study in patients on olanzapine, clozapine or risperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Humans; Olanzapine; Piperazines; Prospective Studies; Risperidone | 2023 |
Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Erectile Dysfunction; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Mentally Ill Persons; Olanzapine; Pregnancy; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone | 2023 |
Antipsychotics Induced Reproductive Toxicity by Stimulating Oxidative Stress: A Comparative in Vivo and in Silico Study.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Haloperidol; Male; Quetiapine Fumarate; Rats; Risperidone; Semen | 2023 |
Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China.
Topics: Antipsychotic Agents; Aripiprazole; China; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Humans; Olanzapine; Risperidone; Schizophrenia; Weight Gain | 2023 |
Editorial: A Better Perspective on Antipsychotic-Related Hyperprolactinemia in Children and Adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Dopamine; Female; Humans; Hyperprolactinemia; Male; Prolactin; Risperidone | 2023 |
Therapeutic outcomes wide association scan of different antipsychotics in patients with schizophrenia: Randomized clinical trials and multi-ancestry validation.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Hyperprolactinemia; Lipids; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Multiomics; Olanzapine; Phospholipases; Precision Medicine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2023 |
Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Humans; Male; Olanzapine; Rhabdomyolysis; Risperidone | 2023 |
Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis.
Topics: Adolescent; Adolescent, Hospitalized; Antipsychotic Agents; Aripiprazole; Humans; Marijuana Abuse; Program Evaluation; Psychotic Disorders; Retrospective Studies; Risperidone; Substance-Related Disorders | 2023 |